syndrome	score	normalized_score
MYOCLONIC EPILEPSY OF LAFORA	1.5356746999999997	100.0
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	1.5	97.6769363980536
#180550 RING DERMOID OF CORNEA; RDC	1.3596488	88.53755290752659
PERIPHERAL CONE DYSTROPHY	1.333333	86.82392175895066
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.3055556	85.01511420354846
RETINITIS PIGMENTOSA 18	1.166667	75.97097223780533
RETINITIS PIGMENTOSA 75; RP75	1.1	71.62975335857263
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	1.0311747820000001	67.1479957311272
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	1.017427681	66.2528125911041
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	1.01651193	66.19318075631514
CRI-DU-CHAT SYNDROME	1.00833333	65.66060702829837
MOWAT-WILSON SYNDROME; MOWS	1.000915751	65.17758943349136
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	1.0	65.11795759870239
Leber congenital amaurosis 17	1.0	65.11795759870239
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 5	1.0	65.11795759870239
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.9484126	61.75869147287509
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.886880351	57.751837091540295
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.833333	54.26494295959946
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.833333	54.26494295959946
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.67656799	44.056725685459305
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.6388886	41.60312076509434
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.556471351	36.23627783931064
207720 APNEA, CENTRAL SLEEP;;SLEEP APNEA, LETHAL CENTRAL	0.5555556	36.176646004521665
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.5513401819999999	35.90214659393685
#616152 MACULAR DYSTROPHY, VITELLIFORM, 5; VMD5	0.5434783	35.39019689521486
#121200 SEIZURES, BENIGN FAMILIAL NEONATAL, 1; BFNS1EPILEPSY, BENIGN NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED;;SEIZURES, BENIGN FAMILIAL NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED	0.537771982	35.01861312164615
WILLIAMS-BEUREN SYNDROME; WBS	0.53013259	34.52115151731029
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.5287904000000001	34.43375084580089
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.5188679	33.787617911527754
EPILEPSY, BENIGN NEONATAL, 2	0.5147059	33.516596972001956
PREECLAMPSIA/ECLAMPSIA 1	0.504732541	32.86715220352331
#300672 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2;;INFANTILE SPASM SYNDROME, X-LINKED 2; ISSX2	0.504508033	32.852532701098745
LEIGH SYNDROME; LS	0.5017596329999999	32.673562506434465
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.500843882	32.613930671645505
#614265 COMBINED MALONIC AND METHYLMALONIC ACIDURIA; CMAMMA	0.500843882	32.613930671645505
COMBINED SAPOSIN DEFICIENCY	0.5	32.558978799351195
MACULAR DYSTROPHY, VITELLIFORM, 4; VMD4	0.5	32.558978799351195
#605115 HYPERTENSION, EARLY-ONSET, AUTOSOMAL DOMINANT, WITH SEVERE EXACERBATIONIN PREGNANCY	0.5	32.558978799351195
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.5	32.558978799351195
GLAUCOMA 1, OPEN ANGLE, F; GLC1F	0.5	32.558978799351195
RETINITIS PIGMENTOSA AND ERYTHROCYTIC MICROCYTOSIS; RPEM	0.5	32.558978799351195
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.5	32.558978799351195
#177700 GLAUCOMA 1, OPEN ANGLE, P; GLC1P	0.5	32.558978799351195
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	32.558978799351195
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.488691082	31.822565156539994
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.472238	30.751174060496023
#604403 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2; GEFSP2;;GEFS+, TYPE 2; GEFS+2FEBRILE SEIZURES, FAMILIAL, 3A, INCLUDED; FEB3A, INCLUDED	0.46636890000000003	30.36899025555348
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.4619261	30.07968419353396
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.4619261	30.07968419353396
CENTRALOPATHIC EPILEPSY	0.4484126	29.199712673523898
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.40966448	26.676514238334466
TUBEROUS SCLEROSIS	0.38841575100000003	25.29284040428615
OPTIC ATROPHY 1; OPA1	0.38370785	24.986271506589258
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.38370785	24.986271506589258
#605751 SEIZURES, BENIGN FAMILIAL INFANTILE, 2; BFIS2;;CONVULSIONS, BENIGN FAMILIAL INFANTILE, 2; BFIC2	0.3824787	24.906231769006816
#602066 CONVULSIONS, FAMILIAL INFANTILE, WITH PAROXYSMAL CHOREOATHETOSIS;ICCA;;INFANTILE CONVULSIONS AND PAROXYSMAL CHOREOATHETOSIS, FAMILIAL;;ICCA SYNDROME;;PAROXYSMAL KINESIGENIC DYSKINESIA WITH INFANTILE CONVULSIONS; PKD/IC	0.3824787	24.906231769006816
BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD	0.378811	24.66739863592205
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.3752738	24.43706339630392
EPILEPSY, JUVENILE ABSENCE	0.3752738	24.43706339630392
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.36331538199999996	23.65835564003236
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.362568782	23.609738572889167
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.36135160000000005	23.530478167023272
#607682 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 9; EIG9EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 6, INCLUDED; EJM6,INCLUDED	0.3596488	23.419595308824196
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.353044782	22.98955514471913
#535000 LEBER OPTIC ATROPHY;;LEBER HEREDITARY OPTIC NEUROPATHY; LHON	0.3508769	22.84838709656414
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.3480389	22.663582332899022
ALLAN-HERNDON-DUDLEY SYNDROME	0.34166633	22.24861358984426
OPTIC ATROPHY 9; OPA9	0.34022955	22.155053410725596
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.33509263300000003	21.820547867331545
CHROMOSOME 16p13.2 DELETION SYNDROME	0.33509263300000003	21.820547867331545
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.33509263300000003	21.820547867331545
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.335092633	21.82054786733154
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.334248751	21.765595995037234
%108650 SPASTIC ATAXIA 7, AUTOSOMAL DOMINANT; SPAX7;;SPASTIC ATAXIA WITH CONGENITAL MIOSIS;;MIOSIS, CONGENITAL, WITH SPASTIC ATAXIA	0.333333	21.705964160248264
MYOTONIA, POTASSIUM-AGGRAVATED	0.333333	21.705964160248264
SUDDEN INFANT DEATH SYNDROME	0.333333	21.705964160248264
#244400 CILIARY DYSKINESIA, PRIMARY, 1; CILD1;;PCD;;CILIARY DYSKINESIA, PRIMARY, 1, WITH OR WITHOUT SITUS INVERSUS;;IMMOTILE CILIA SYNDROME; ICS;;POLYNESIAN BRONCHIECTASISKARTAGENER SYNDROME, INCLUDED;;DEXTROCARDIA, BRONCHIECTASIS, AND SINUSITIS, INCLUDED;;SIEWERT SYNDROME, INCLUDED	0.333333	21.705964160248264
#607208 DRAVET SYNDROME;;EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 6; EIEE6;;SEVERE MYOCLONIC EPILEPSY OF INFANCY; SMEI	0.331292682	21.573102819236396
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.33074978200000005	21.537750280056063
AICARDI SYNDROME; AIC	0.325	21.16333621957828
#601152 HEREDITARY MOTOR AND SENSORY NEUROPATHY VI;;HMSN6;;HMSN VI;;PERIPHERAL NEUROPATHY AND OPTIC ATROPHY;;CHARCOT-MARIE-TOOTH DISEASE, TYPE 6; CMT6	0.2934783	19.110707495539263
OPTIC ATROPHY 5; OPA5	0.2934783	19.110707495539263
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.281174782	18.30952753210039
RETINOSCHISIS OF FOVEA	0.27715928	18.048046243126883
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.27306608200000004	17.781505549319792
JOUBERT SYNDROME 5	0.267857	17.44230076851563
CATARACT 7; CTRCT7	0.2675439	17.421912335991475
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.265549782	17.292059444620662
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.2647059	17.237107572326355
HYPEREKPLEXIA 1; HKPX1	0.2635135	17.159460919685664
NYSTAGMUS 2, CONGENITAL, AUTOSOMAL DOMINANT; NYS2	0.26306939	17.130541383536503
NYSTAGMUS 1, CONGENITAL, X-LINKED; NYS1	0.25689655	16.72857865015293
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.250915751	16.339121234464567
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.25	16.279489399675597
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25	16.279489399675597
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.25	16.279489399675597
CONE-ROD DYSTROPHY 11; CORD11	0.25	16.279489399675597
#604364 EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI; FFEVF;;EPILEPSY, PARTIAL, WITH VARIABLE FOCI; FPEVF	0.25	16.279489399675597
#613587 OCCULT MACULAR DYSTROPHY; OCMD;;OMD	0.25	16.279489399675597
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.2244281	14.61429949975734
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.2244281	14.61429949975734
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.2244281	14.61429949975734
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.2244281	14.61429949975734
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.2244281	14.61429949975734
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.21554978200000002	14.036161564685546
#613826 LEBER CONGENITAL AMAUROSIS 6; LCA6	0.20202009999999998	13.155136305885614
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.200843882	13.078543392034787
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.194414082	12.65984794826665
LATE-ONSET RETINAL DEGENERATION; LORD	0.19411189	12.640169822423983
#300814 NYSTAGMUS 6, CONGENITAL, X-LINKED; NYS6	0.1929828	12.566645787678866
RETINITIS PIGMENTOSA 58	0.1909091	12.431610679006434
CONE-ROD DYSTROPHY 2	0.18353164	11.951205551540312
RETINAL CONE DYSTROPHY 3B	0.18333370000000002	11.938316103013227
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.182315233	11.871995612091547
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.182143382	11.860805025960254
#613863 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 7; GEFSP7;;GEFS+, TYPE 7; GEFS+7FEBRILE SEIZURES, FAMILIAL, 3B, INCLUDED; FEB3B, INCLUDED	0.1812995	11.805853153665945
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.17973639000000002	11.704066622963838
OPTIC ATROPHY 3, AUTOSOMAL DOMINANT	0.17356355	11.302103889580263
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.167510882	10.90796651139724
#607476 NEWFOUNDLAND ROD-CONE DYSTROPHY; NFRCD	0.166667	10.853014639102932
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.166667	10.853014639102932
%300589 NYSTAGMUS 5, CONGENITAL, X-LINKED; NYS5	0.166667	10.853014639102932
MUCOLIPIDOSIS III ALPHA/BETA	0.166667	10.853014639102932
SENIOR-LOKEN SYNDROME 3	0.16040089999999999	10.444979004993701
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.15986995	10.410404625406672
CHROMOSOME 1P36 DELETION SYNDROME	0.157253753	10.240043220090818
#613341 LEBER CONGENITAL AMAUROSIS 14; LCA14RETINAL DYSTROPHY, EARLY-ONSET SEVERE, LRAT-RELATED, INCLUDED;;RETINITIS PIGMENTOSA, JUVENILE, LRAT-RELATED, INCLUDED	0.14975354999999999	9.751645319155159
MIRAGE SYNDROME; MIRAGE	0.14843342299999995	9.665681345144254
#613722 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 12; EIEE12	0.1471846	9.584360541981972
#615369 EPILEPTIC ENCEPHALOPATHY, CHILDHOOD-ONSET; EEOC	0.146374782	9.531626847795307
LEBER CONGENITAL AMAUROSIS 5; LCA5	0.14444311999999998	9.40584096358428
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.14377275099999998	9.362187903466795
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.14370088199999997	9.357507940972134
CURRARINO SYNDROME	0.14370088199999997	9.357507940972134
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.14370088199999997	9.357507940972134
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.14285699999999998	9.302556068677827
POLYCYSTIC KIDNEY, CATARACT, AND CONGENITAL BLINDNESS	0.14285699999999998	9.302556068677827
LEBER CONGENITAL AMAUROSIS 12; LCA12	0.14285699999999998	9.302556068677827
RETICULAR DYSGENESIA	0.14285699999999998	9.302556068677827
LEUKOCYTE ADHESION DEFICIENCY, TYPE III	0.14285699999999998	9.302556068677827
%179900 RETINAL APLASIA;;AMAUROSIS CONGENITA	0.14285699999999998	9.302556068677827
IMMUNODEFICIENCY 46; IMD46	0.14285699999999998	9.302556068677827
WHITE-SUTTON SYNDROME; WHSUS	0.141210462	9.195336877009176
#615473 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 17; EIEE17	0.14054978199999998	9.152314744782863
MENTAL RETARDATION, X-LINKED 106; MRX106	0.13827068199999998	9.003904407619661
#613060 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 10; EIG10GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 5, SUSCEPTIBILITYTO, INCLUDED; GEFS5, INCLUDED;;GEFS+, TYPE 5, SUSCEPTIBILITY TO, INCLUDED;;GEFS+5, SUSCEPTIBILITY TO, INCLUDED;;GEFSP5, SUSCEPTIBILITY TO, INCLUDED;;EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 7, INCLUDED; EJM7,INCLUDED	0.1344245	8.75344889122677
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.13423833300000002	8.741326076414493
JOUBERT SYNDROME 2	0.132016722	8.596659305515681
JOUBERT SYNDROME 3; JBTS3	0.13117284	8.541707433221374
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.12881679	8.38828626922095
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.12675963299999998	8.254328406921076
TUBEROUS SCLEROSIS 2; TSC2	0.125915751	8.199376534626769
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIx;;CDG-x	0.125915751	8.199376534626769
JOUBERT SYNDROME 7	0.125843882	8.194696572132107
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.125843882	8.194696572132107
JOUBERT SYNDROME 1	0.125843882	8.194696572132107
#604233 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 1; GEFSP1;;GEFS+, TYPE 1; GEFS+1	0.1257439	8.188185948495473
#611722 KRABBE DISEASE, ATYPICAL, DUE TO SAPOSIN A DEFICIENCY;;SAPOSIN A DEFICIENCY	0.125	8.139744699837799
LEBER CONGENITAL AMAUROSIS 8; LCA8	0.12418038999999999	8.086373370610325
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.123997613	8.07447130567431
CONE-ROD DYSTROPHY 10	0.1222222	7.9588600372201235
LEBER CONGENITAL AMAUROSIS WITH EARLY-ONSET DEAFNESS; LCAEOD	0.11800754999999999	7.684410637226752
SENIOR-LOKEN SYNDROME 4; SLSN4	0.1172249	7.6334460677121285
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.1115527	7.264083988620769
MICROPHTHALMIA WITH HYPEROPIA, RETINAL DEGENERATION, MACROPHAKIA,AND DENTAL ANOMALIES	0.11111099999999999	7.23532138674942
HYPEROPIA, HIGH	0.11111099999999999	7.23532138674942
MICROPHTHALMIA, ISOLATED 6; MCOP6	0.11111099999999999	7.23532138674942
MICROPHTHALMIA, ISOLATED 1	0.11111099999999999	7.23532138674942
CONE-ROD DYSTROPHY 8; CORD8	0.10990099	7.1565280068754165
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.10906923100000002	7.102365559581078
APNEA, OBSTRUCTIVE SLEEP	0.10818720000000001	7.044929502322336
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.1081087	7.039817742650838
ALAND ISLAND EYE DISEASE	0.1075758	7.005116383046489
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D	0.10737463300000001	6.992016798870232
CONE-ROD DYSTROPHY 6; CORD6	0.10689655	6.960885010347571
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.10172584100000001	6.624179000930343
#262600 PITUITARY HORMONE DEFICIENCY, COMBINED, 2; CPHD2;;PANHYPOPITUITARISM;;ATELIOTIC DWARFISM WITH HYPOGONADISM;;PITUITARY DWARFISM III;;HANHART DWARFISM	0.10091575100000001	6.57142759465921
Retinitis pigmentosa with or without skeletal anomalies	0.10084388200000001	6.566747632164548
HERMANSKY-PUDLAK SYNDROME 1; HPS1	0.10081009	6.564547166141373
#613767 RETINITIS PIGMENTOSA 45; RP45	0.1	6.51179575987024
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.1	6.51179575987024
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.1	6.51179575987024
RETINITIS PIGMENTOSA 41	0.1	6.51179575987024
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.1	6.51179575987024
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.1	6.51179575987024
3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY	0.1	6.51179575987024
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.1	6.51179575987024
#613810 RETINITIS PIGMENTOSA 43; RP43	0.1	6.51179575987024
#256450 HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1; HHF1;;PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; PHHI;;HYPOGLYCEMIA, HYPERINSULINEMIC, OF INFANCY;;HYPERINSULINEMIC HYPOGLYCEMIA DUE TO FOCAL ADENOMATOUS HYPERPLASIA;;NESIDIOBLASTOSIS OF PANCREAS;;HYPERINSULINISM, FAMILIAL, WITH PANCREATIC NESIDIOBLASTOSIS;;HYPERINSULINISM, CONGENITAL	0.1	6.51179575987024
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.1	6.51179575987024
RETINITIS PIGMENTOSA 20	0.09708194	6.321777652519771
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.096634882	6.292666148631609
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.094246682	6.137151442294388
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.09415004100000002	6.130858377754093
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.09128048200000001	5.943998556465117
#262300 ACHROMATOPSIA 3; ACHM3;;PINGELAPESE BLINDNESS;;TOTAL COLORBLINDNESS WITH MYOPIA;;ACHROMATOPSIA WITH MYOPIA;;ACHM1, FORMERLY;;ROD MONOCHROMATISM 1, FORMERLY;;ROD MONOCHROMACY 1, FORMERLY; RMCH1, FORMERLY	0.0909091	5.919814919136196
CATARACT, CONGENITAL TOTAL, WITH POSTERIOR SUTURAL OPACITIES IN HETEROZYGOTES	0.0909091	5.919814919136196
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.0909091	5.919814919136196
#612438 LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6;;LEUKODYSTROPHY, HYPOMYELINATING, WITH ATROPHY OF THE BASAL GANGLIAAND CEREBELLUM; HABC	0.09042189100000002	5.888088864132491
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.089731551	5.843135333283802
#614018 EPILEPSY, PROGRESSIVE MYOCLONIC, 6; EPM6	0.0888158	5.783503498494832
CANAVAN DISEASE	0.08682409	5.653807411165921
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.0852273	5.549827707651889
ADENYLOSUCCINASE DEFICIENCY	0.08509293300000002	5.541078003043225
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.08509293300000002	5.541078003043225
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.08509293300000002	5.541078003043225
#608804 LEUKODYSTROPHY, HYPOMYELINATING, 2; HLD2;;PELIZAEUS-MERZBACHER-LIKE DISEASE, 1; PMLD1	0.08509293300000002	5.541078003043225
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.08417718200000002	5.481446168254255
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.08333330000000001	5.426494295959947
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.08333330000000001	5.426494295959947
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.08309594000000001	5.411037897544318
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.082715282	5.386250226040711
RHEUMATOID ARTHRITIS	0.08136789999999999	5.298511462095456
TYSHCHENKO SYNDROME	0.080624472	5.250100949113769
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.0788689	5.1357816860562995
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.078621682	5.119683354814663
#612437 EPILEPSY, PROGRESSIVE MYOCLONIC 1B; EPM1B	0.078125	5.087340437398624
LISSENCEPHALY 2; LIS2	0.07776698200000001	5.064027036455053
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.077380532	5.038862201741034
MENTAL RETARDATION, X-LINKED 98; MRX98	0.07727423300000001	5.03194022796625
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.07692310000000001	5.009075164160745
#615604 L-FERRITIN DEFICIENCY; LFTD	0.07692310000000001	5.009075164160745
MCLEOD SYNDROME; MCLDS	0.07692310000000001	5.009075164160745
MYOCLONUS AND ATAXIA	0.07692310000000001	5.009075164160745
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.076358482	4.97230839317728
PRADER-WILLI SYNDROME; PWS	0.075263943	4.901034248985154
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.0744235	4.846306317347028
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.0744235	4.846306317347028
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.074030841	4.820737165234279
COSTELLO SYNDROME; CSTLO	0.073883682	4.811154471712012
OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7	0.07363065	4.794677544664896
#615233 RETINITIS PIGMENTOSA 66; RP66	0.07363065	4.794677544664896
CONE-ROD DYSTROPHY 20; CORD20	0.07363065	4.794677544664896
#143200 WAGNER VITREORETINOPATHY; WGVRP;;EROSIVE VITREORETINOPATHY; ERVR;;WAGNER VITREORETINAL DEGENERATION;;HYALOIDEORETINAL DEGENERATION OF WAGNER;;WAGNER SYNDROME 1; WGN1	0.07309950000000001	4.760090141486346
BARATELA-SCOTT SYNDROME	0.07306618200000001	4.757920541375073
BAKER-GORDON SYNDROME; BAGOS	0.070905652	4.617231240444347
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.0702615	4.575285377821229
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.0702615	4.575285377821229
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.068475733	4.458999878034066
HALLERMANN-STREIFF SYNDROME; HSS	0.0673375	4.384880469802622
CONE-ROD DYSTROPHY, X-LINKED, 3	0.06704155	4.365608810251286
POTOCKI-LUPSKI SYNDROME	0.066930613	4.358384819389159
#270100 HETEROTAXY, VISCERAL, 5, AUTOSOMAL; HTX5;;SITUS INVERSUS VISCERUM; SIV	0.06631679	4.318413919302051
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.06631679	4.318413919302051
MARSHALL-SMITH SYNDROME; MRSHSS	0.0661451	4.307233817161929
CRANIOSYNOSTOSIS 2	0.06608673100000001	4.303432947094852
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.066046082	4.300785967236422
SCHAAF-YANG SYNDROME; SHFYNG	0.06564856300000001	4.274900341849743
RETINITIS PIGMENTOSA 4; RP4	0.06545659000000001	4.262399452175647
CHROMOSOME 17q12 DELETION SYNDROME	0.06517098	4.243801112305881
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.064163	4.178163513405542
DYSOSTEOSCLEROSIS	0.063448341	4.13162637894601
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.063415751	4.129504184707869
HYDROXYKYNURENINURIA	0.063343882	4.124824222213208
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.063343882	4.124824222213208
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.0632439	4.118313598576575
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.0632439	4.118313598576575
CROUZON SYNDROME	0.062644191	4.079261773343014
PSEUDOTRISOMY 13 SYNDROME	0.0625	4.069872349918899
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	0.0625	4.069872349918899
178610 PULMONARY NODULAR LYMPHOID HYPERPLASIA, FAMILIAL	0.0625	4.069872349918899
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.0625	4.069872349918899
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.0625	4.069872349918899
HEMOSIDEROSIS, PULMONARY, WITH DEFICIENCY OF GAMMA-A GLOBULIN	0.0625	4.069872349918899
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.0625	4.069872349918899
FASCIAL DYSTROPHY, CONGENITAL	0.0625	4.069872349918899
LICHTENSTEIN SYNDROME	0.0625	4.069872349918899
%153840 MACULAR DYSTROPHY, VITELLIFORM, 1; VMD1;;MACULAR DYSTROPHY, ATYPICAL VITELLIFORM	0.062452150000000005	4.066756455647802
USHER SYNDROME, TYPE IIIA	0.062452150000000005	4.066756455647802
#229300 FRIEDREICH ATAXIA 1; FRDA;;FRDA1;;FAFRIEDREICH ATAXIA WITH RETAINED REFLEXES, INCLUDED; FARR, INCLUDED	0.062452150000000005	4.066756455647802
CAVITARY OPTIC DISC ANOMALIES; CODA	0.062452150000000005	4.066756455647802
RETINITIS PIGMENTOSA 78; RP78	0.062452150000000005	4.066756455647802
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.061132023	3.9807924816368994
OPTIC ATROPHY 8	0.061022200000000006	3.9736410321795375
#604116 CONE-ROD DYSTROPHY 3; CORD3	0.061022200000000006	3.9736410321795375
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.059913013	3.9014130401445053
#254770 EPILEPSY, MYOCLONIC JUVENILE; EJM;;MYOCLONIC EPILEPSY, JUVENILE; JME;;PETIT MAL, IMPULSIVE;;JANZ SYNDROMEMYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 1, INCLUDED; EJM1,INCLUDED	0.0598896	3.8998884334032464
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.059372390000000004	3.866208774553622
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.057490582	3.743669281000723
#269921 SIALURIA;;SIALURIA, FRENCH TYPE	0.057315233	3.7322509122537486
TURNPENNY-FRY SYNDROME; TPFS	0.057292272	3.730755738829324
EPILEPSY, IDIOPATHIC GENERALIZED	0.0566467	3.688717408706415
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.056471351	3.6772990399594403
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.056399482	3.672619077464779
RETINITIS PIGMENTOSA 62; RP62	0.055555600000000004	3.617667205170471
#300491 EPILEPSY, X-LINKED, WITH VARIABLE LEARNING DISABILITIES AND BEHAVIORDISORDERS	0.055555600000000004	3.617667205170471
#613809 RETINITIS PIGMENTOSA 39; RP39	0.055555600000000004	3.617667205170471
APNEA, CENTRAL SLEEP	0.055555600000000004	3.617667205170471
NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 1	0.055555600000000004	3.617667205170471
GLAUCOMA - SLEEP APNEA	0.055555600000000004	3.617667205170471
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.055555600000000004	3.617667205170471
#615651 LEUKOENCEPHALOPATHY WITH ATAXIA; LKPAT	0.055555600000000004	3.617667205170471
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.055555600000000004	3.617667205170471
#300643 ROLANDIC EPILEPSY, MENTAL RETARDATION, AND SPEECH DYSPRAXIA, X-LINKED;RESDX	0.055555600000000004	3.617667205170471
CHROMOSOME Xq26.3 DUPLICATION SYNDROME	0.055555600000000004	3.617667205170471
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.055555600000000004	3.617667205170471
SPASTIC PARAPLEGIA 74, AUTOSOMAL RECESSIVE; SPG74	0.055555600000000004	3.617667205170471
#609923 RETINITIS PIGMENTOSA 31; RP31	0.055555600000000004	3.617667205170471
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.055555600000000004	3.617667205170471
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.055555600000000004	3.617667205170471
#615725 RETINITIS PIGMENTOSA 68; RP68	0.055555600000000004	3.617667205170471
AMYOTROPHIC LATERAL SCLEROSIS 1	0.055555600000000004	3.617667205170471
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.055555600000000004	3.617667205170471
#156200 MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1CHROMOSOME 2q23.1 DELETION SYNDROME, INCLUDED	0.054677119999999996	3.5604623817791623
MUCOPOLYSACCHARIDOSIS, TYPE II	0.053547351	3.486894131940834
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.053475482	3.482214169446173
XIA-GIBBS SYNDROME	0.053475482	3.482214169446173
HURLER-SCHEIE SYNDROME	0.0526316	3.4272622971518647
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.0526316	3.4272622971518647
SCHEIE SYNDROME	0.0526316	3.4272622971518647
#615156 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS,AUTOSOMAL DOMINANT, 6; PEOA6;;PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL DOMINANT, 6	0.0526316	3.4272622971518647
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.0526316	3.4272622971518647
MARFANOID HABITUS WITH SITUS INVERSUS	0.0526316	3.4272622971518647
RAHMAN SYNDROME	0.052159712000000004	3.396533914376529
ALSTROM SYNDROME; ALMS	0.051544572	3.356477253939263
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.051218732	3.3352592186353016
#304700 MOHR-TRANEBJAERG SYNDROME; MTS;;DYSTONIA-DEAFNESS SYNDROME; DDS;;DEAFNESS-DYSTONIA-OPTIC ATROPHY SYNDROME; DDP;;DEAFNESS SYNDROME, PROGRESSIVE, WITH BLINDNESS, DYSTONIA, FRACTURES,AND MENTAL DEFICIENCY	0.05040969	3.2825760559837316
MACULAR DYSTROPHY, RETINAL, 1, NORTH CAROLINA TYPE	0.050374850000000006	3.2803073463409937
MACULAR DYSTROPHY WITH CENTRAL CONE INVOLVEMENT; CCMD	0.050374850000000006	3.2803073463409937
MACULAR DYSTROPHY, RETINAL, 3; MCDR3	0.050374850000000006	3.2803073463409937
OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES	0.050374850000000006	3.2803073463409937
ACHROMATOPSIA 7; ACHM7	0.050374850000000006	3.2803073463409937
MACULAR DYSTROPHY, RETINAL, 2	0.050374850000000006	3.2803073463409937
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.050297633	3.2752791330090942
EPILEPSY, PYRIDOXINE-DEPENDENT	0.050042682	3.2586772446013477
#610127 CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10;;CEROID LIPOFUSCINOSIS, NEURONAL, CATHEPSIN D-DEFICIENT;;NEURONAL CEROID LIPOFUSCINOSIS DUE TO CATHEPSIN D DEFICIENCYNEURONAL CEROID LIPOFUSCINOSIS, CONGENITAL, INCLUDED	0.0499253	3.2510335685024963
CONE-ROD DYSTROPHY 17; CORD17	0.04965114	3.233180829247236
FEBRILE CONVULSIONS, FAMILIAL, 9	0.048538	3.1606954259258164
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.048538	3.1606954259258164
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.0476583	3.1034111586262383
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.0476583	3.1034111586262383
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.047216733	3.0746572174432516
#303110 CHOROIDEREMIA, DEAFNESS, AND MENTAL RETARDATION;;CHROMOSOME Xq21 DELETION SYNDROME	0.046321882	3.016386347968096
#616341 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 30; EIEE30	0.045880682	2.9876563050755482
#303100 CHOROIDEREMIA; CHM;;TAPETOCHOROIDAL DYSTROPHY, PROGRESSIVE; TCDCHOROIDAL SCLEROSIS, INCLUDED	0.045478000000000005	2.9614344756737876
#300868 MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2	0.045259282	2.9471920062237142
#610951 CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7	0.043913772000000004	2.8595751430950846
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.043549572	2.835859182937637
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.043546151	2.8356364144046915
RETINAL DYSTROPHY WITH INNER RETINAL DYSFUNCTION AND GANGLION CELL ABNORMALITIES; RDGCA	0.043478300000000004	2.8312180958636626
RETINAL DYSTROPHY WITH OR WITHOUT MACULAR STAPHYLOMA; RDMS	0.043478300000000004	2.8312180958636626
CONE-ROD DYSTROPHY 18	0.043478300000000004	2.8312180958636626
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.0429825	2.7989326124862255
%300843 BORNHOLM EYE DISEASE; BED;;MYOPIA, HIGH, WITH NONPROGRESSIVE CONE DYSFUNCTION	0.0429825	2.7989326124862255
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.0429825	2.7989326124862255
PEHO-LIKE SYNDROME; PEHOL	0.042751012	2.783858586717617
BETA-UREIDOPROPIONASE DEFICIENCY	0.042751012	2.783858586717617
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.042355842000000005	2.7581259234133384
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.042126212999999996	2.7431729519279053
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.041865582	2.726201193520998
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.041865582	2.726201193520998
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0415952	2.7085944699095457
#614652 COENZYME Q10 DEFICIENCY, PRIMARY, 3; COQ10D3	0.04128573	2.6884424155714752
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.041210461999999996	2.6835411171389363
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.041210461999999996	2.6835411171389363
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.0410217	2.6712493212266897
SCLEROSTEOSIS 1; SOST1	0.0407997	2.656793134639778
#604232 LEBER CONGENITAL AMAUROSIS 3; LCA3RETINITIS PIGMENTOSA, JUVENILE, SPATA7-RELATED, INCLUDED	0.0407997	2.656793134639778
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.040590522	2.6431718905051964
RETINITIS PIGMENTOSA 11	0.04005334	2.6081916958064104
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.0397661	2.589487213665759
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.03974664	2.5882200182108885
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.039508112	2.572687562020785
HERMANSKY-PUDLAK SYNDROME 8; HPS8	0.03935147	2.562487354906609
GAUCHER DISEASE, PERINATAL LETHAL	0.038654241	2.5170852264480237
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.037255682	2.4260139207867395
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.0369281	2.4046824500006414
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.0369281	2.4046824500006414
OPTIC ATROPHY 11; OPA11	0.036775062	2.3947169280056513
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.036775062	2.3947169280056513
RETINAL CONE DYSTROPHY 4	0.03632519	2.3654221821848083
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.0362408	2.3599268777430535
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.03593118	2.3397650557113434
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.034712032999999996	2.260376693058758
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.034417682	2.2412091571216224
#613721 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11; EIEE11	0.034417682	2.2412091571216224
#257300 MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1;;MVA SYNDROME	0.034147689999999994	2.2236278295136334
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.034022512	2.2154764938173432
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.033882823	2.206380231438338
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.033809703	2.2016188063787214
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.0335738	2.186257284827314
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.0331689	2.1598910237955997
BARDET-BIEDL SYNDROME 21; BBS21	0.03315679	2.1591024453290792
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.033093682	2.1549929812609405
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.033038941	2.15142835914403
RETINITIS PIGMENTOSA 80; RP80	0.032967072	2.146748396649369
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.0329524	2.1457929859754805
RETINAL DEGENERATION WITH NANOPHTHALMOS, CYSTIC MACULAR DEGENERATION,AND ANGLE CLOSURE GLAUCOMA	0.03287118	2.140504105459314
LEBER CONGENITAL AMAUROSIS 15; LCA15	0.03287118	2.140504105459314
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.032817033	2.1369781634092173
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2; CFEOM2	0.03248864	2.1155938819595064
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0323814	2.1086106321866214
#615516 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38; MRT38	0.032315163	2.1042974140291566
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.03212319	2.091796524355061
#610189 SENIOR-LOKEN SYNDROME 6; SLSN6	0.03193729	2.079691096037462
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.031892223000000004	2.0767564250423614
RETINOSCHISIS 1, X-LINKED, JUVENILE; RS1	0.031837580000000004	2.0731981844852956
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.031121539999999996	2.0265711221263203
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.030942752	2.0149288127231637
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.030550033	1.989355753532959
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.030550033	1.989355753532959
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.030550033	1.989355753532959
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.030550033	1.989355753532959
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.030550033	1.989355753532959
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.030550032999999997	1.9893557535329585
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.030550032999999997	1.9893557535329585
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.0303309	1.9750862601304826
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.0303309	1.9750862601304826
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.0303309	1.9750862601304826
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.0303309	1.9750862601304826
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.0303309	1.9750862601304826
RETINITIS PIGMENTOSA 72; RP72	0.03015235	1.963459448801234
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.03015235	1.963459448801234
RETINITIS PIGMENTOSA 14	0.03015235	1.963459448801234
RETINITIS PIGMENTOSA 19	0.03015235	1.963459448801234
CHERUBISM	0.03015235	1.963459448801234
RETINITIS PIGMENTOSA 10; RP10	0.03015235	1.963459448801234
RETINITIS PIGMENTOSA 83; RP83	0.03015235	1.963459448801234
RETINITIS PIGMENTOSA 79	0.03015235	1.963459448801234
JACOBSEN SYNDROME	0.03013259	1.9621727179590838
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.029706151	1.9344038812386506
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.029706151	1.9344038812386506
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.029701412	1.9340952872375905
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.029634281999999998	1.9297239187439894
#616351 MENTAL RETARDATION, AUTOSOMAL DOMINANT 34; MRD34	0.029634281999999998	1.9297239187439894
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.029310791	1.9086588455224276
CONE DYSTROPHY 3	0.029118750000000002	1.8961535278272152
CONE-ROD DYSTROPHY 16	0.029118750000000002	1.8961535278272152
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.028513750999999997	1.8567572285979579
COFFIN-SIRIS SYNDROME 1; CSS1	0.028415963	1.8503894737602962
Adrenoleukodystrophy	0.028360641	1.8467870181100206
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.028340672999999997	1.8454867427326895
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.028075433	1.82821485565921
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.028075433	1.82821485565921
Muenke syndrome	0.028075433	1.82821485565921
DIGEORGE SYNDROME; DGS	0.028075433	1.82821485565921
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.028045112	1.8262404140668598
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.028041713	1.8260190781289816
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.028041713	1.8260190781289816
#301835 ARTS SYNDROME; ARTS;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARTS TYPE; MRXSARTS;;ATAXIA, FATAL X-LINKED, WITH DEAFNESS AND LOSS OF VISION;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 18; MRXS18	0.027636863	1.7996560729951472
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.027231551	1.7732629833649018
#248250 HYPOMAGNESEMIA 3, RENAL; HOMG3;;HYPOMAGNESEMIA, PRIMARY, DUE TO DEFECT IN RENAL TUBULAR TRANSPORTOF MAGNESIUM;;HYPOMAGNESEMIA, ISOLATED RENAL;;HYPOMAGNESEMIA, FAMILIAL, WITH HYPERCALCIURIA AND NEPHROCALCINOSISHYPERCALCIURIA, CHILDHOOD, SELF-LIMITING, INCLUDED	0.027197831	1.7710672058346735
HAREL-YOON SYNDROME; HAYOS	0.027159682	1.7685830208702407
MENTAL RETARDATION, X-LINKED 41	0.027159682	1.7685830208702407
#600638 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULARINVOLVEMENT; CFEOM3A;;FEOM3 LOCUS	0.027159682	1.7685830208702407
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.027159682	1.7685830208702407
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.027159682	1.7685830208702407
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.027159682	1.7685830208702407
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.027159682	1.7685830208702407
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.026954741	1.755237681522005
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.026458512	1.7229242625407586
#604356 DUANE RETRACTION SYNDROME 2; DURS2	0.0263158	1.7136311485759324
CATARACT 19, MULTIPLE TYPES; CTRCT19	0.0263158	1.7136311485759324
MYOCLONIC-ATONIC EPILEPSY	0.0263158	1.7136311485759324
#616311 MENTAL RETARDATION, AUTOSOMAL DOMINANT 33; MRD33	0.0263158	1.7136311485759324
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.0263158	1.7136311485759324
CATARACT 2, MULTIPLE TYPES; CTRCT2	0.0263158	1.7136311485759324
CATARACT 17, MULTIPLE TYPES	0.0263158	1.7136311485759324
CHROMOSOME Xp11.23-p11.22 DUPLICATION SYNDROME	0.0263158	1.7136311485759324
#612269 EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 5; ECA5	0.0263158	1.7136311485759324
CATARACT, ANTERIOR POLAR, 2	0.0263158	1.7136311485759324
OPHTHALMOPLEGIA TOTALIS WITH PTOSIS AND MIOSIS	0.0263158	1.7136311485759324
CATARACT 9, MULTIPLE TYPES; CTRCT9	0.0263158	1.7136311485759324
SPONDYLOOCULAR SYNDROME; SOS	0.0263158	1.7136311485759324
HEMIFACIAL HYPERPLASIA WITH STRABISMUS	0.0263158	1.7136311485759324
MENTAL AND GROWTH RETARDATION WITH AMBLYOPIA	0.0263158	1.7136311485759324
RETINOPATHY, PERICENTRAL PIGMENTARY, AUTOSOMAL RECESSIVE	0.02628208	1.7114353710457042
SOTOS SYNDROME 2	0.02628208	1.7114353710457042
#108145 ARTHROGRYPOSIS, DISTAL, TYPE 5; DA5;;ARTHROGRYPOSIS WITH OCULOMOTOR LIMITATION AND ELECTRORETINAL ABNORMALITIES;;OCULOMELIC AMYOPLASIA;;ARTHROGRYPOSIS, DISTAL, TYPE IIB; DAIIB	0.02628208	1.7114353710457042
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.026080913	1.6983357868694462
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.025984623	1.692065578732267
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.025984623	1.692065578732267
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.025984623	1.692065578732267
FUMARASE DEFICIENCY; FMRD	0.025884622	1.685553717854439
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.025884622	1.685553717854439
XYLOSIDASE DEFICIENCY	0.025522641	1.661982254444903
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.025476373	1.6589693767827267
ZTTK SYNDROME; ZTTKS	0.025459513	1.6578714880176124
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.025140740999999998	1.6371137064379586
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.025068872	1.6324337439432977
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.025068872	1.6324337439432977
ROIFMAN SYNDROME; RFMN	0.025068872	1.6324337439432977
ALPHA-METHYLACYL-CoA RACEMASE DEFICIENCY; AMACRD	0.02504074	1.6306018455601308
#220120 D-GLYCERIC ACIDURIA;;D-GLYCERIC ACIDEMIA;;GLYCERATE KINASE DEFICIENCY	0.024798862999999997	1.6148513093300294
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.024798862999999997	1.6148513093300294
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.024486933	1.5945390648162663
YUNIS-VARON SYNDROME	0.02422499	1.5774818716489896
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.02422499	1.5774818716489896
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.02422499	1.5774818716489896
Diamond-Blackfan anemia 1	0.02422499	1.5774818716489896
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.02422499	1.5774818716489896
RESTRICTIVE DERMOPATHY, LETHAL	0.02422499	1.5774818716489896
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.02422499	1.5774818716489896
TEMPLE SYNDROME	0.02422499	1.5774818716489896
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.024177463	1.574387010478196
PHELAN-MCDERMID SYNDROME; PHMDS	0.024177463	1.574387010478196
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.024177463	1.574387010478196
CHROMOSOME 14q11-q22 DELETION SYNDROME	0.024177463	1.574387010478196
2,4-DIENOYL-CoA REDUCTASE DEFICIENCY; DECRD	0.024177463	1.574387010478196
#520000 DIABETES AND DEAFNESS, MATERNALLY INHERITED; MIDD;;DIABETES-DEAFNESS SYNDROME, MATERNALLY TRANSMITTED;;BALLINGER-WALLACE SYNDROME;;DIABETES MELLITUS, TYPE II, WITH DEAFNESS;;NONINSULIN-DEPENDENT DIABETES MELLITUS WITH DEAFNESS;;NIDDM WITH DEAFNESS	0.024171551	1.5740020331128726
#222448 DONNAI-BARROW SYNDROME;;FACIOOCULOACOUSTICORENAL SYNDROME;;DBS/FOAR SYNDROME;;DIAPHRAGMATIC HERNIA, EXOMPHALOS, ABSENT CORPUS CALLOSUM, HYPERTELORISM,MYOPIA, SENSORINEURAL DEAFNESS, AND PROTEINURIA	0.023981833	1.5616479844331619
#609304 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 3; EIEE3	0.02395833	1.5601175170757196
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.02371674	1.5443856696994491
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.023643050999999998	1.5395871925219582
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.023643050999999998	1.5395871925219582
RETINAL DYSTROPHY AND OBESITY; RDOB	0.02356325	1.5343907143876243
MEGALOCORNEA	0.02356325	1.5343907143876243
EDICT SYNDROME	0.02356325	1.5343907143876243
ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A	0.02356325	1.5343907143876243
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.023528572	1.5321325538540165
RETINITIS PIGMENTOSA 6	0.0232558	1.514370198323903
#608133 RETINITIS PIGMENTOSA 7; RP7RETINITIS PIGMENTOSA 7, DIGENIC, INCLUDED;;RETINITIS PIGMENTOSA 7 WITH BULL'S-EYE MACULOPATHY, INCLUDED	0.0232558	1.514370198323903
GLAUCOMA 1, OPEN ANGLE, M	0.0232558	1.514370198323903
RETINITIS PIGMENTOSA	0.0232558	1.514370198323903
RETINITIS PIGMENTOSA 1	0.0232558	1.514370198323903
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND DEMENTIA	0.0232558	1.514370198323903
#612572 RETINITIS PIGMENTOSA 46; RP46;;RETINITIS PIGMENTOSA, AUTOSOMAL RECESSIVE, IDH3B-RELATED	0.0232558	1.514370198323903
#606068 RETINITIS PIGMENTOSA 28; RP28	0.0232558	1.514370198323903
RETINITIS PIGMENTOSA 73; RP73	0.0232558	1.514370198323903
#608380 RETINITIS PIGMENTOSA 26; RP26	0.0232558	1.514370198323903
RETINITIS PIGMENTOSA 13; RP13	0.0232558	1.514370198323903
#180104 RETINITIS PIGMENTOSA 9; RP9	0.0232558	1.514370198323903
RETINITIS PIGMENTOSA 74; RP74	0.0232558	1.514370198323903
RETINITIS PIGMENTOSA 69	0.0232558	1.514370198323903
#312600 RETINITIS PIGMENTOSA 2; RP2	0.0232558	1.514370198323903
#613769 RETINITIS PIGMENTOSA 44; RP44	0.0232558	1.514370198323903
RETINITIS PIGMENTOSA 25; RP25	0.0232558	1.514370198323903
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.023137951	1.5066961121388536
NEURAMINIDASE DEFICIENCY	0.023137951	1.5066961121388536
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.023137951	1.5066961121388536
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.023137951	1.5066961121388536
#256731 CEROID LIPOFUSCINOSIS, NEURONAL, 5; CLN5;;CEROID LIPOFUSCINOSIS, NEURONAL, 5, VARIABLE AGE AT ONSETNEURONAL CEROID LIPOFUSCINOSIS, LATE INFANTILE, FINNISH VARIANT, INCLUDED;;FINNISH vLINCL, INCLUDED	0.023137951	1.5066961121388536
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.023137951	1.5066961121388536
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.023066082	1.5020161496441926
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.023066082	1.5020161496441926
JOUBERT SYNDROME 35; JBTS35	0.023066082	1.5020161496441926
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.023066082	1.5020161496441926
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.023066082	1.5020161496441926
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C	0.023066082	1.5020161496441926
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.023066082	1.5020161496441926
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.023066082	1.5020161496441926
#608836 CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, ANTENATAL;;CPT II DEFICIENCY, LETHAL NEONATAL;;CPT2 DEFICIENCY, LETHAL NEONATAL	0.022762580999999997	1.4822527843950284
#184095 SPONDYLOEPIPHYSEAL DYSPLASIA, MAROTEAUX TYPE;;SED, MAROTEAUX TYPE;;PSEUDO-MORQUIO SYNDROME, TYPE 2	0.0227273	1.479955357732989
OSTEOGENESIS IMPERFECTA, TYPE V	0.0227273	1.479955357732989
PREPAPILLARY VASCULAR LOOPS	0.0227273	1.479955357732989
LARYNGOONYCHOCUTANEOUS SYNDROME	0.0227273	1.479955357732989
BLEPHAROCHALASIS AND DOUBLE LIP	0.0227273	1.479955357732989
IMINOGLYCINURIA	0.0227273	1.479955357732989
OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	0.0227273	1.479955357732989
AGNATHIA-OTOCEPHALY COMPLEX	0.0227273	1.479955357732989
SETTING-SUN PHENOMENON, FAMILIAL BENIGN	0.0227273	1.479955357732989
PUPIL, EGG-SHAPED	0.0227273	1.479955357732989
MELKERSSON-ROSENTHAL SYNDROME	0.0227273	1.479955357732989
DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12	0.0227273	1.479955357732989
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.0227273	1.479955357732989
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.0227273	1.479955357732989
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5	0.0227273	1.479955357732989
#609242 KANZAKI DISEASE;;ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, TYPE II;;ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, ADULT-ONSET;;NAGA DEFICIENCY, TYPE II;;SCHINDLER DISEASE, TYPE II	0.0227273	1.479955357732989
#600208 MACROTHROMBOCYTOPENIA AND PROGRESSIVE SENSORINEURAL DEAFNESS	0.0227273	1.479955357732989
HYPERCALCEMIA, INFANTILE, 1	0.0227273	1.479955357732989
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1	0.0227273	1.479955357732989
LEVATOR-MEDIAL RECTUS SYNKINESIS	0.0227273	1.479955357732989
%271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE;;BRACHYOLMIA, RECESSIVE TYPE OF HOBAEK;;SPONDYLODYSPLASIA WITH PURE BRACHYOLMIA	0.0227273	1.479955357732989
611426 TENTED EYEBROWS	0.0227273	1.479955357732989
DERMOIDS OF CORNEA	0.0227273	1.479955357732989
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0227273	1.479955357732989
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0227273	1.479955357732989
MYDRIATIC RESPONSE TO PHARMACOLOGIC AGENTS	0.0227273	1.479955357732989
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.0227273	1.479955357732989
SEA-BLUE HISTIOCYTE DISEASE	0.0227273	1.479955357732989
ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA	0.0227273	1.479955357732989
CARNEY COMPLEX, TYPE 1; CNC1	0.0227273	1.479955357732989
GAUCHER DISEASE, TYPE I	0.0227273	1.479955357732989
MYELINATED OPTIC NERVE FIBERS	0.0227273	1.479955357732989
OCULAR CICATRICIAL PEMPHIGOID	0.0227273	1.479955357732989
UNIQUE GREEN PHENOMENON	0.0227273	1.479955357732989
STICKLER SYNDROME, TYPE III	0.0227273	1.479955357732989
%300700 ALBINISM-DEAFNESS SYNDROME; ADFN;;ALDS	0.0227273	1.479955357732989
MELANOMA, CUTANEOUS MALIGNANT	0.0227273	1.479955357732989
SCHOPF-SCHULZ-PASSARGE SYNDROME; SSPS	0.0227273	1.479955357732989
#103470 ALBINISM, OCULAR, WITH SENSORINEURAL DEAFNESS;;WAARDENBURG SYNDROME, TYPE 2, WITH OCULAR ALBINISM, AUTOSOMAL RECESSIVE;WS2-OA	0.02268477	1.477185890996316
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii; CDG1I	0.022638372999999996	1.4741646131176087
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.022638372999999996	1.4741646131176087
LOWE OCULOCEREBRORENAL SYNDROME	0.022318471	1.453333248245869
COHEN SYNDROME	0.022318471	1.453333248245869
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.0222222	1.4470642773498843
612867 CORNEAL DYSTROPHY, SUBEPITHELIAL MUCINOUS; SMCD;;SUBEPITHELIAL MUCINOUS CORNEAL DYSTROPHY	0.0222222	1.4470642773498843
CORNEAL DYSTROPHY, LATTICE TYPE I	0.0222222	1.4470642773498843
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.0222222	1.4470642773498843
BEHR SYNDROME	0.0222222	1.4470642773498843
#613660 CONE-ROD DYSTROPHY 15; CORD15RETINITIS PIGMENTOSA 65, INCLUDED; RP65, INCLUDED	0.0222222	1.4470642773498843
#608940 SPONDYLOMETAPHYSEAL DYSPLASIA WITH CONE-ROD DYSTROPHY; SMDCRD	0.0222222	1.4470642773498843
RETINAL CONE DYSTROPHY 1; RCD1	0.0222222	1.4470642773498843
MACULAR DEGENERATION, AGE-RELATED, 13; ARMD13	0.0222222	1.4470642773498843
SPINOCEREBELLAR ATAXIA 7 OPCA III OPCA WITH RETINAL DEGENERATION OPCA WITH MACULAR DEGENERATION AND EXTERNAL OPHTHALMOPLEGIA AUTOSOMAL DOMINANT CEREBELLAR ATAXIA, TYPE II ADCA, TYPE II	0.0222222	1.4470642773498843
MACULAR DEGENERATION, AGE-RELATED, 1; ARMD1	0.0222222	1.4470642773498843
#610048 CORNEAL DYSTROPHY, CONGENITAL STROMAL; CSCD;;CONGENITAL STROMAL CORNEAL DYSTROPHY	0.0222222	1.4470642773498843
FUNDUS DYSTROPHY, PSEUDOINFLAMMATORY, RECESSIVE FORM	0.0222222	1.4470642773498843
#613862 RETINITIS PIGMENTOSA 38; RP38;;ROD-CONE DYSTROPHY, CHILDHOOD-ONSET	0.0222222	1.4470642773498843
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.0222222	1.4470642773498843
EXUDATIVE VITREORETINOPATHY 6; EVR6	0.0222222	1.4470642773498843
BASAL LAMINAR DRUSEN	0.0222222	1.4470642773498843
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.0222222	1.4470642773498843
%115665 CATARACT, CONGENITAL, VOLKMANN TYPE; CCV	0.0222222	1.4470642773498843
MENTAL RETARDATION, X-LINKED 77	0.0222222	1.4470642773498843
Boucher-Neuhauser syndrome	0.0222222	1.4470642773498843
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.0222222	1.4470642773498843
EPILEPSY, HOT WATER, 1	0.0222222	1.4470642773498843
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79	0.0222222	1.4470642773498843
ANIRIDIA 3	0.0222222	1.4470642773498843
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.0222222	1.4470642773498843
JOUBERT SYNDROME 30; JBTS30	0.022169683	1.4436444775706734
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.022167832999999998	1.4435240093491155
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.022167832999999998	1.4435240093491155
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.022167832999999998	1.4435240093491155
KAGAMI-OGATA SYNDROME	0.022167832999999998	1.4435240093491155
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.022167832999999998	1.4435240093491155
INFANTILE SIALIC ACID STORAGE DISEASE	0.022167832999999998	1.4435240093491155
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.022167832999999998	1.4435240093491155
NEMALINE MYOPATHY 2; NEM2	0.021846829999999998	1.4226209496060591
#614653 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VI; HSAN6;;HSAN VI	0.021846829999999998	1.4226209496060591
#614706 CEROID LIPOFUSCINOSIS, NEURONAL, 11; CLN11	0.02179784	1.4194308208632989
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.021445973	1.3965179604769162
CORNELIA DE LANGE SYNDROME 1	0.021399241	1.3934748680824136
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.021327372	1.3887949055877526
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.021323950999999997	1.3885721370548074
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.021252082	1.3838921745601462
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.021252082	1.3838921745601462
HYPERPROLINEMIA, TYPE I	0.020627533	1.3432228192598346
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.02048349	1.3338430332934443
RENPENNING SYNDROME 1; RENS1	0.020432120999999998	1.3304979889295565
KNIEST-LIKE DYSPLASIA, LETHAL	0.020408199999999998	1.328940302265838
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.020408199999999998	1.328940302265838
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.020408199999999998	1.328940302265838
#609152 HYPERTHYROIDISM, NONAUTOIMMUNE;;HYPERTHYROIDISM, CONGENITAL NONAUTOIMMUNE;;HYPERTHYROIDISM, NONAUTOIMMUNE, AUTOSOMAL DOMINANT;;TOXIC THYROID HYPERPLASIA, AUTOSOMAL DOMINANT	0.020408199999999998	1.328940302265838
CORNEODERMATOOSSEOUS SYNDROME	0.020408199999999998	1.328940302265838
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.020408199999999998	1.328940302265838
#215045 CHONDRODYSPLASIA, BLOMSTRAND TYPE; BOCD	0.020408199999999998	1.328940302265838
#242500 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4B; ARCI4B;;ICHTHYOSIS CONGENITA, HARLEQUIN FETUS TYPE;;HARLEQUIN ICHTHYOSIS; HI;;'HARLEQUIN FETUS'	0.020408199999999998	1.328940302265838
#267450 RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS;;RDS OF PREMATURITY;;HYALINE MEMBRANE DISEASE, FORMERLY	0.020408199999999998	1.328940302265838
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.020408199999999998	1.328940302265838
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.020408199999999998	1.328940302265838
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.020408199999999998	1.328940302265838
#225410 EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL RECESSIVE;;EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE;;DERMATOSPARAXIS;;EDS VIIC;;EDS7C	0.020408199999999998	1.328940302265838
NEMALINE MYOPATHY 10	0.020408199999999998	1.328940302265838
#214700 DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL; DIAR1;;CHLORIDE DIARRHEA, CONGENITAL, FINNISH TYPE;;CHLORIDORRHEA, CONGENITAL	0.020408199999999998	1.328940302265838
ATELOSTEOGENESIS, TYPE I; AO1	0.020408199999999998	1.328940302265838
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.020408199999999998	1.328940302265838
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.020408199999999998	1.328940302265838
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.020282322999999998	1.3207434491171863
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.020082593	1.3077374394459975
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.019711782	1.283590984470865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.019711782	1.283590984470865
Congenital disorder of glycosylation, type IIh	0.019711782	1.283590984470865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.019711782	1.283590984470865
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.019711782	1.283590984470865
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.019711782	1.283590984470865
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.019711782	1.283590984470865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.019711782	1.283590984470865
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.019711782	1.283590984470865
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.019711782	1.283590984470865
RING CHROMOSOME 14 SYNDROME	0.019711782	1.283590984470865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.019711782	1.283590984470865
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.019708343	1.2833670438146831
#117550 SOTOS SYNDROME 1; SOTOS1;;SOTOS SYNDROME;;CEREBRAL GIGANTISM;;CHROMOSOME 5q35 DELETION SYNDROME	0.019708343	1.2833670438146831
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.019366572	1.2611116143282168
#249270 THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 1 (MEGALOBLASTIC ANEMIA,DIABETES MELLITUS, AND DEAFNESS TYPE); THMD1;;MEGALOBLASTIC ANEMIA, THIAMINE-RESPONSIVE, WITH DIABETES MELLITUSAND SENSORINEURAL DEAFNESS;;ROGERS SYNDROME;;THIAMINE-RESPONSIVE ANEMIA SYNDROME;;THIAMINE-RESPONSIVE MYELODYSPLASIA	0.019303533	1.2570066433991525
#300653 PHOSPHOGLYCERATE KINASE 1 DEFICIENCY;;PGK1 DEFICIENCY	0.019303533	1.2570066433991525
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.019303533	1.2570066433991525
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.019303533	1.2570066433991525
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.019303533	1.2570066433991525
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0188679	1.228639112176557
ANDROSTENONE, ABILITY TO SMELL	0.0188679	1.228639112176557
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.0188679	1.228639112176557
MYOPATHY, CONGENITAL	0.0188679	1.228639112176557
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0188679	1.228639112176557
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0188679	1.228639112176557
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0188679	1.228639112176557
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0188679	1.228639112176557
DIASTEMATOMYELIA	0.0188679	1.228639112176557
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0188679	1.228639112176557
JUMPING FRENCHMAN OF MAINE	0.0188679	1.228639112176557
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0188679	1.228639112176557
CARDIAC ARRHYTHMIA	0.0188679	1.228639112176557
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0188679	1.228639112176557
ENDOCARDIAL FIBROELASTOSIS	0.0188679	1.228639112176557
SPASTIC PSEUDOSCLEROSIS	0.0188679	1.228639112176557
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0188679	1.228639112176557
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0188679	1.228639112176557
PERONEAL NERVE, ACCESSORY DEEP	0.0188679	1.228639112176557
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.0188679	1.228639112176557
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0188679	1.228639112176557
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0188679	1.228639112176557
COGNITIVE FUNCTION 1, SOCIAL	0.0188679	1.228639112176557
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0188679	1.228639112176557
MERALGIA PARAESTHETICA, FAMILIAL	0.0188679	1.228639112176557
SPATIAL VISUALIZATION, APTITUDE FOR	0.0188679	1.228639112176557
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0188679	1.228639112176557
ALCOHOL DEPENDENCE	0.0188679	1.228639112176557
141405 HEMIFACIAL SPASM, FAMILIAL	0.0188679	1.228639112176557
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0188679	1.228639112176557
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0188679	1.228639112176557
CERVICAL RIB	0.0188679	1.228639112176557
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0188679	1.228639112176557
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0188679	1.228639112176557
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0188679	1.228639112176557
#259420 OSTEOGENESIS IMPERFECTA, TYPE III;;OI, TYPE III;;OI3;;OSTEOGENESIS IMPERFECTA, PROGRESSIVELY DEFORMING, WITH NORMAL SCLERAE	0.0188679	1.228639112176557
PALMOMENTAL REFLEX	0.0188679	1.228639112176557
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0188679	1.228639112176557
THUMBS, CONGENITAL CLASPED	0.0188679	1.228639112176557
ERYTHERMALGIA, PRIMARY	0.0188679	1.228639112176557
#601277 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A;;ICHTHYOSIS CONGENITA IIB; ICR2B;;ICHTHYOSIS, LAMELLAR, 2, FORMERLY; LI2, FORMERLY	0.0188679	1.228639112176557
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0188679	1.228639112176557
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0188679	1.228639112176557
GRANULOMAS, CONGENITAL CEREBRAL	0.0188679	1.228639112176557
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0188679	1.228639112176557
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0188679	1.228639112176557
MOTION SICKNESS	0.0188679	1.228639112176557
269800 SENILE PLAQUE FORMATION	0.0188679	1.228639112176557
NOVELTY SEEKING PERSONALITY TRAIT	0.0188679	1.228639112176557
#220100 CYSTINURIA;;CSNU;;CYSTINURIA, TYPE I, FORMERLY; CSNU1, FORMERLY;;CYSTINURIA, TYPE II, FORMERLY;;CYSTINURIA, TYPE III, FORMERLY; CSNU3, FORMERLY;;CYSTINURIA, TYPE NON-I, FORMERLYCYSTINURIA, TYPE A, INCLUDED;;CYSTINURIA, TYPE B, INCLUDED;;CYSTINURIA, TYPE A/B, INCLUDED	0.0188679	1.228639112176557
TRANSSEXUALITY	0.0188679	1.228639112176557
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.018792592	1.2237352090257139
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.018459651	1.2020547711048442
KNOBLOCH SYNDROME 1; KNO1	0.018459651	1.2020547711048442
#125310 CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTSAND LEUKOENCEPHALOPATHY; CADASIL;;DEMENTIA, HEREDITARY MULTI-INFARCT TYPE;;CASIL	0.018459651	1.2020547711048442
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.018459651	1.2020547711048442
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.018426333	1.1998851709935707
OCULOECTODERMAL SYNDROME; OES	0.018426333	1.1998851709935707
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.018426333	1.1998851709935707
DESANTO-SHINAWI SYNDROME	0.018426333	1.1998851709935707
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.018426333	1.1998851709935707
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.018426333	1.1998851709935707
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.018246040999999998	1.1881449241821853
#612285 JOUBERT SYNDROME 9; JBTS9JOUBERT SYNDROME 9/15, DIGENIC, INCLUDED	0.017582451	1.1449332986992624
PITT-HOPKINS SYNDROME	0.017582451	1.1449332986992624
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.017547853	1.1426803476022624
Helsmoortel-van der Aa syndrome	0.017547853	1.1426803476022624
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.017547853	1.1426803476022624
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.0175439	1.142422936315875
PEROXISOME BIOGENESIS DISORDER 11B	0.0175439	1.142422936315875
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.0175439	1.142422936315875
SPASTIC PARAPLEGIA 57, AUTOSOMAL RECESSIVE; SPG57	0.0175439	1.142422936315875
OPTICOCOCHLEODENTATE DEGENERATION	0.0175439	1.142422936315875
SPLENOMEGALY, CYTOPENIA, AND VISION LOSS	0.0175439	1.142422936315875
BRITTLE CORNEA SYNDROME	0.0175439	1.142422936315875
NANCE-HORAN SYNDROME	0.0175439	1.142422936315875
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.0175439	1.142422936315875
RETINAL ARTERIES, TORTUOSITY OF	0.0175439	1.142422936315875
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.0175439	1.142422936315875
#276900 USHER SYNDROME, TYPE I; USH1;;US1;;RETINITIS PIGMENTOSA AND CONGENITAL DEAFNESSUSHER SYNDROME, TYPE IB, INCLUDED; USH1B, INCLUDED;;USHER SYNDROME, TYPE IA, FORMERLY, INCLUDED; USH1A, FORMERLY, INCLUDED;;USHER SYNDROME, TYPE I, FRENCH VARIETY, FORMERLY, INCLUDED	0.0175439	1.142422936315875
LEBER OPTIC ATROPHY AND DYSTONIA	0.0175439	1.142422936315875
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.0175439	1.142422936315875
VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS	0.0175439	1.142422936315875
CATARACT 44; CTRCT44	0.0175439	1.142422936315875
SPASTIC QUADRIPLEGIA, RETINITIS PIGMENTOSA, AND MENTAL RETARDATION	0.0175439	1.142422936315875
OSTEOPETROSIS, AUTOSOMAL DOMINANT 2	0.0175439	1.142422936315875
ANTIPHOSPHOLIPID SYNDROME, FAMILIAL	0.0175439	1.142422936315875
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.0175439	1.142422936315875
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.0175439	1.142422936315875
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.017510582	1.1402533362046015
BARDET-BIEDL SYNDROME 1; BBS1	0.017510582	1.1402533362046015
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.017510582	1.1402533362046015
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.017510582	1.1402533362046015
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.017510582	1.1402533362046015
DYSTONIA 28, CHILDHOOD-ONSET	0.017510582	1.1402533362046015
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.017384633	1.1320517945630024
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.016989513	1.1063223871566032
EXUDATIVE VITREORETINOPATHY 4	0.01679754	1.0938214974825073
#133780 EXUDATIVE VITREORETINOPATHY 1; EVR1;;EXUDATIVE VITREORETINOPATHY, FAMILIAL, AUTOSOMAL DOMINANT;;FEVR, AUTOSOMAL DOMINANT;;CRISWICK-SCHEPENS SYNDROMERETINOPATHY OF PREMATURITY, INCLUDED; ROP, INCLUDED	0.01679754	1.0938214974825073
LEBER CONGENITAL AMAUROSIS 4; LCA4	0.01679754	1.0938214974825073
SIFRIM-HITZ-WEISS SYNDROME	0.0166667	1.0853014639102931
VAN BOGAERT-HOZAY SYNDROME	0.0166667	1.0853014639102931
HYPOMAGNESEMIA 5, RENAL, WITH OR WITHOUT OCULAR INVOLVEMENT; HOMG5	0.0166667	1.0853014639102931
#253250 MULIBREY NANISM;;MUSCLE-LIVER-BRAIN-EYE NANISM;;PERICARDIAL CONSTRICTION AND GROWTH FAILURE;;PERHEENTUPA SYNDROME	0.0166667	1.0853014639102931
#148300 KERATOCONUS 1; KTCN1	0.0166667	1.0853014639102931
#614134 STICKLER SYNDROME, TYPE IV; STL4	0.0166667	1.0853014639102931
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.0166667	1.0853014639102931
HYPEREKPLEXIA 2; HKPX2	0.0166667	1.0853014639102931
SVEINSSON CHORIORETINAL ATROPHY	0.0166667	1.0853014639102931
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.0166667	1.0853014639102931
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.016540751	1.077099922268694
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.016540751	1.077099922268694
MICROPHTHALMIA, ISOLATED 5	0.01651193	1.075223157612742
#611809 BESTROPHINOPATHY, AUTOSOMAL RECESSIVE; ARB	0.01651193	1.075223157612742
VISUAL IMPAIRMENT AND PROGRESSIVE PHTHISIS BULBI; VIPB	0.01651193	1.075223157612742
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.016468882	1.0724199597740331
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.016468882	1.0724199597740331
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.016468882	1.0724199597740331
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.016468882	1.0724199597740331
#300848 MENTAL RETARDATION, X-LINKED 89; MRX89	0.016468882	1.0724199597740331
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.016468882	1.0724199597740331
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.016468882	1.0724199597740331
#614457 ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR	0.016468882	1.0724199597740331
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.016468882	1.0724199597740331
ROIFMAN-CHITAYAT SYNDROME	0.016468882	1.0724199597740331
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.016468882	1.0724199597740331
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.016465533	1.0722018797340351
PEHO SYNDROME; PEHO	0.016465533	1.0722018797340351
#613668 MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY	0.016465533	1.0722018797340351
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.016465533	1.0722018797340351
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.016465533	1.0722018797340351
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.016465533	1.0722018797340351
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.016465533	1.0722018797340351
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.016465533	1.0722018797340351
HYPEREKPLEXIA 4; HKPX4	0.016465533	1.0722018797340351
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.016465533	1.0722018797340351
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.016465533	1.0722018797340351
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm; CDG2M	0.016465533	1.0722018797340351
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.016465533	1.0722018797340351
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.016465533	1.0722018797340351
#226750 KOHLSCHUTTER-TONZ SYNDROME; KTZS;;EPILEPSY AND YELLOW TEETH;;EPILEPSY, DEMENTIA, AND AMELOGENESIS IMPERFECTA;;KOHLSCHUTTER SYNDROME	0.016465533	1.0722018797340351
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.016465533	1.0722018797340351
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.016265803	1.059195870062846
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.016265803	1.059195870062846
#300004 CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA;;ACC WITH ABNORMAL GENITALIA;;PROUD SYNDROME	0.016265803	1.059195870062846
CHROMOSOME Xp11.3 DELETION SYNDROME	0.01607383	1.0466949803887504
RETINITIS PIGMENTOSA 27; RP27	0.01607383	1.0466949803887504
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.015844133	1.0317375808822014
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.015844133	1.0317375808822014
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.015844133	1.0317375808822014
SCHINDLER DISEASE, TYPE I	0.015844133	1.0317375808822014
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.015844133	1.0317375808822014
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.015844133	1.0317375808822014
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.015844133	1.0317375808822014
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.015844133	1.0317375808822014
Glycosylphosphatidylinositol biosynthesis defect 18	0.015844133	1.0317375808822014
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.015844133	1.0317375808822014
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.015844133	1.0317375808822014
#615182 COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD	0.015844133	1.0317375808822014
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.015844133	1.0317375808822014
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.015844133	1.0317375808822014
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.015844133	1.0317375808822014
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.015844133	1.0317375808822014
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.015844133	1.0317375808822014
RAYNAUD-CLAES SYNDROME; MRXSRC	0.015844133	1.0317375808822014
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.015844133	1.0317375808822014
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.015844133	1.0317375808822014
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.015844133	1.0317375808822014
HYDROXYLYSINURIA	0.015625	1.0174680874797248
CARNOSINEMIA	0.015625	1.0174680874797248
#231000 GAUCHER DISEASE, TYPE III;;GD III;;GAUCHER DISEASE, SUBACUTE NEURONOPATHIC TYPE;;GAUCHER DISEASE, CHRONIC NEURONOPATHIC TYPE;;GAUCHER DISEASE, JUVENILE AND ADULT, CEREBRALGAUCHER DISEASE, TYPE IIIA, INCLUDED;;GAUCHER DISEASE, TYPE IIIB, INCLUDED;;GAUCHER DISEASE, NORRBOTTNIAN TYPE, INCLUDED	0.015625	1.0174680874797248
#230600 GM1-GANGLIOSIDOSIS, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, JUVENILE TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 2GANGLIOSIDOSIS, GENERALIZED GM1, LATE-INFANTILE TYPE, INCLUDED	0.015625	1.0174680874797248
MICROHYDRANENCEPHALY; MHAC	0.015625	1.0174680874797248
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.015625	1.0174680874797248
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.015625	1.0174680874797248
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.015625	1.0174680874797248
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.015625	1.0174680874797248
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.015625	1.0174680874797248
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.015625	1.0174680874797248
PAINE SYNDROME	0.015625	1.0174680874797248
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.015621650999999999	1.0172500074397268
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.015621650999999999	1.0172500074397268
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.015621650999999999	1.0172500074397268
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.015621650999999999	1.0172500074397268
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.015621650999999999	1.0172500074397268
NEUROFIBROMATOSIS, TYPE I	0.015621650999999999	1.0172500074397268
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.015621650999999999	1.0172500074397268
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.015621650999999999	1.0172500074397268
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, cblX TYPE	0.015621650999999999	1.0172500074397268
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.015621650999999999	1.0172500074397268
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.015621650999999999	1.0172500074397268
#610768 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Im; CDG1M;;CDG Im; CDGIm;;DOLICHOL KINASE DEFICIENCY;;DK1 DEFICIENCY	0.015621650999999999	1.0172500074397268
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.015621650999999999	1.0172500074397268
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.015549782	1.0125700449450656
PELGER-HUET ANOMALY; PHA	0.015549782	1.0125700449450656
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.015549782	1.0125700449450656
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.015549782	1.0125700449450656
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.015549782	1.0125700449450656
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.015549782	1.0125700449450656
#252011 MITOCHONDRIAL COMPLEX II DEFICIENCY;;SUCCINATE CoQ REDUCTASE DEFICIENCY	0.015421920999999998	1.004243997768538
PEROXISOME BIOGENESIS DISORDER 5B	0.015350052	0.9995640352738768
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.015350052	0.9995640352738768
#614873 PEROXISOME BIOGENESIS DISORDER 7B; PBD7B	0.015350052	0.9995640352738768
PEROXISOME BIOGENESIS DISORDER 6B	0.015350052	0.9995640352738768
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J	0.015273133	0.9945552270933423
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.015273133	0.9945552270933423
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.015273133	0.9945552270933423
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.015273133	0.9945552270933423
3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.015273133	0.9945552270933423
GAUCHER DISEASE, TYPE II	0.015273133	0.9945552270933423
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.015273133	0.9945552270933423
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.015273133	0.9945552270933423
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.015273133	0.9945552270933423
#300673 ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS	0.015273133	0.9945552270933423
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.015273133	0.9945552270933423
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.015273133	0.9945552270933423
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.015273133	0.9945552270933423
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.015273133	0.9945552270933423
PROPIONIC ACIDEMIA	0.015273133	0.9945552270933423
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.015273133	0.9945552270933423
WIEACKER-WOLFF SYNDROME	0.015273133	0.9945552270933423
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.015273133	0.9945552270933423
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.015273133	0.9945552270933423
KOOLEN-DE VRIES SYNDROME; KDVS	0.015191803	0.9892591836018397
CHROMOSOME 1p35 DELETION SYNDROME	0.015191803	0.9892591836018397
WITTEVEEN-KOLK SYNDROME	0.015191803	0.9892591836018397
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.015000251	0.9767857085878932
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.015000251	0.9767857085878932
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.015000251	0.9767857085878932
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.015000251	0.9767857085878932
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.015000251	0.9767857085878932
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.014928382	0.972105746093232
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.014928382	0.972105746093232
YOU-HOOVER-FONG SYNDROME; YHFS	0.014928382	0.972105746093232
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC	0.014829023	0.9656356909441826
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.0147059	0.9576181726507574
MYOCLONIC EPILEPSY, JUVENILE, 2	0.0147059	0.9576181726507574
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.0147059	0.9576181726507574
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.0147059	0.9576181726507574
#607876 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 2; FAME2;;BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY 2; BAFME2;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 2; FCMTE2;;CORTICAL MYOCLONUS AND EPILEPSY, AUTOSOMAL DOMINANT; ADCME	0.0147059	0.9576181726507574
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.0147059	0.9576181726507574
EPILEPSY, BENIGN NEONATAL, 3	0.0147059	0.9576181726507574
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.0147059	0.9576181726507574
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.0147059	0.9576181726507574
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.0147059	0.9576181726507574
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.0147059	0.9576181726507574
#104290 ALTERNATING HEMIPLEGIA OF CHILDHOOD 1; AHC1	0.0147059	0.9576181726507574
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.0147059	0.9576181726507574
#612199 CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS; CRMCC;;COATS PLUS SYNDROME	0.014633531	0.9529056511772971
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.014429250999999999	0.939603354799034
TENORIO SYNDROME; TNORS	0.014429250999999999	0.939603354799034
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.014429250999999999	0.939603354799034
HYPOADRENOCORTICISM, FAMILIAL	0.014429250999999999	0.939603354799034
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.014429250999999999	0.939603354799034
HYPOPHOSPHATASIA, INFANTILE	0.014429250999999999	0.939603354799034
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.014429250999999999	0.939603354799034
GLUTAMINE DEFICIENCY, CONGENITAL	0.014429250999999999	0.939603354799034
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.014429250999999999	0.939603354799034
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.014429250999999999	0.939603354799034
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.014429250999999999	0.939603354799034
RETT SYNDROME; RTT	0.014429250999999999	0.939603354799034
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.014429250999999999	0.939603354799034
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.014429250999999999	0.939603354799034
MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY; ECHS1D	0.014357382	0.934923392304373
OROFACIODIGITAL SYNDROME XVI; OFD16	0.014357382	0.934923392304373
JOUBERT SYNDROME 33; JBTS33	0.014357382	0.934923392304373
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.014357382	0.934923392304373
JOUBERT SYNDROME 21	0.014357382	0.934923392304373
JOUBERT SYNDROME 23; JBTS23	0.014357382	0.934923392304373
Myhre syndrome	0.014347921	0.9343073113075316
COCKAYNE SYNDROME A; CSA	0.014347921	0.9343073113075316
#133540 COCKAYNE SYNDROME, TYPE B; CSB;;CKN2	0.014347921	0.9343073113075316
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.014276052000000001	0.9296273488128705
SUDANOPHILIC CEREBRAL SCLEROSIS	0.0140845	0.9171538737989239
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.0140845	0.9171538737989239
#214500 CHEDIAK-HIGASHI SYNDROME; CHS	0.013985141	0.9106838186498745
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.013909753	0.9057747060624235
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.0135135	0.8799715200100647
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.0135135	0.8799715200100647
#600072 FATAL FAMILIAL INSOMNIA; FFI;;INSOMNIA, FATAL FAMILIAL	0.0135135	0.8799715200100647
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.0135135	0.8799715200100647
CAMPOMELIC DYSPLASIA	0.0135135	0.8799715200100647
BUTYRYLCHOLINESTERASE	0.0135135	0.8799715200100647
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.0135135	0.8799715200100647
#614618 HYPEREKPLEXIA 3; HKPX3	0.0135135	0.8799715200100647
STUVE-WIEDEMANN SYNDROME	0.0135135	0.8799715200100647
#613869 MYOPATHY, MYOFIBRILLAR, FATAL INFANTILE HYPERTONIC, ALPHA-B CRYSTALLIN-RELATED;;MFM, FATAL INFANTILE HYPERTONIC, ALPHA-B CRYSTALLIN-RELATED	0.0135135	0.8799715200100647
MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	0.0135135	0.8799715200100647
#610921 SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 3; SMDP3;;PULMONARY ALVEOLAR PROTEINOSIS, CONGENITAL, 3;;INTERSTITIAL LUNG DISEASE DUE TO ABCA3 DEFICIENCY	0.0135135	0.8799715200100647
AURICULOCONDYLAR SYNDROME 2; ARCND2	0.0135135	0.8799715200100647
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.0135135	0.8799715200100647
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.0135135	0.8799715200100647
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.0135135	0.8799715200100647
DUBOWITZ SYNDROME	0.01343217	0.8746754765185624
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.01343217	0.8746754765185624
FONTAINE PROGEROID SYNDROME; FPS	0.01343217	0.8746754765185624
#165550 OPTIC NERVE HYPOPLASIA, BILATERALOPTIC NERVE APLASIA, BILATERAL, INCLUDED	0.01306939	0.8510519838609052
MACULAR DYSTROPHY, VITELLIFORM, 2; VMD2	0.01306939	0.8510519838609052
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.01306939	0.8510519838609052
#270700 SPASTIC PARAPLEGIA 15, AUTOSOMAL RECESSIVE; SPG15;;SPASTIC PARAPLEGIA AND RETINAL DEGENERATION;;KJELLIN SYNDROME	0.01306939	0.8510519838609052
CONE DYSTROPHY 4	0.01306939	0.8510519838609052
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.01306939	0.8510519838609052
#608471 CORNEAL DYSTROPHY, LATTICE TYPE IIIA; CDL3A;;LATTICE CORNEAL DYSTROPHY, TYPE IIIA	0.01306939	0.8510519838609052
#608233 HERMANSKY-PUDLAK SYNDROME 2; HPS2	0.01306939	0.8510519838609052
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.01306939	0.8510519838609052
#258501 3-@METHYLGLUTACONIC ACIDURIA, TYPE III; MGCA3;;MGA, TYPE III; MGA3;;OPTIC ATROPHY PLUS SYNDROME;;OPTIC ATROPHY, INFANTILE, WITH CHOREA AND SPASTIC PARAPLEGIA;;IRAQI-JEWISH 'OPTIC ATROPHY PLUS';;COSTEFF SYNDROME;;OPTIC ATROPHY 3, AUTOSOMAL RECESSIVE;;OPA3, AUTOSOMAL RECESSIVE	0.01306939	0.8510519838609052
PANCREATITIS, SCLEROSING CHOLANGITIS, AND SICCA COMPLEX	0.01306939	0.8510519838609052
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.01306939	0.8510519838609052
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.01306939	0.8510519838609052
LEBER CONGENITAL AMAUROSIS 11; LCA11	0.01306939	0.8510519838609052
#300071 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A; CSNB2A;;CSNB, INCOMPLETE, X-LINKED;;NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2; CSNB2	0.01306939	0.8510519838609052
#615431 MYOPIA 23, AUTOSOMAL RECESSIVE; MYP23	0.01306939	0.8510519838609052
BLUE CONE MONOCHROMACY; BCM	0.01306939	0.8510519838609052
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.013065871	0.8508228337681152
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.01215012	0.7911909989791459
#603358 GRACILE SYNDROME;;GROWTH RETARDATION, AMINO ACIDURIA, CHOLESTASIS, IRON OVERLOAD, LACTICACIDOSIS, AND EARLY DEATH;;FINNISH LETHAL NEONATAL METABOLIC SYNDROME; FLNMS;;LACTIC ACIDOSIS, FINNISH, WITH HEPATIC HEMOSIDEROSIS;;FELLMAN SYNDROME	0.01215012	0.7911909989791459
COFFIN-SIRIS SYNDROME 3; CSS3	0.011749263	0.7650880098500028
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.011749263	0.7650880098500028
COFFIN-SIRIS SYNDROME 4; CSS4	0.011749263	0.7650880098500028
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.011749263	0.7650880098500028
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.011749263	0.7650880098500028
WEBB-DATTANI SYNDROME; WEDAS	0.011660623	0.7593159540884539
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.011660623	0.7593159540884539
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.011660623	0.7593159540884539
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.011660623	0.7593159540884539
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.011660623	0.7593159540884539
#603387 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME;MPPH;;MEGALENCEPHALY, POLYMICROGYRIA, MEGA CORPUS CALLOSUM SYNDROME;;MEG-PMG-MEGACC SYNDROME;;MEGALENCEPHALY, MEGA CORPUS CALLOSUM, AND COMPLETE LACK OF MOTOR DEVELOPMENT	0.011660623	0.7593159540884539
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.011660623	0.7593159540884539
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.011660623	0.7593159540884539
GM2-GANGLIOSIDOSIS, AB VARIANT	0.011660623	0.7593159540884539
#614845 NEPHRONOPHTHISIS 15; NPHP15	0.011660623	0.7593159540884539
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.011375013	0.7407176142186885
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.011375013	0.7407176142186885
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.011375013	0.7407176142186885
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.011375013	0.7407176142186885
FILIPPI SYNDROME; FLPIS	0.010905380999999999	0.7101361375556946
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.010905380999999999	0.7101361375556946
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.010905380999999999	0.7101361375556946
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.010833512	0.7054561750610336
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.010833512	0.7054561750610336
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.010816741	0.7043640817941457
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.010816741	0.7043640817941457
TAY-SACHS DISEASE; TSD	0.010816741	0.7043640817941457
MICROPHTHALMIA, SYNDROMIC 1	0.010816741	0.7043640817941457
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.010816741	0.7043640817941457
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.010816741	0.7043640817941457
#310600 NORRIE DISEASE; ND;;ATROPHIA BULBORUM HEREDITARIA;;EPISKOPI BLINDNESS	0.010816741	0.7043640817941457
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.010816741	0.7043640817941457
KRABBE DISEASE	0.010816741	0.7043640817941457
ARIMA SYNDROME	0.010744872	0.6996841192994846
JOUBERT SYNDROME 6	0.010744872	0.6996841192994846
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.010744872	0.6996841192994846
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.010744872	0.6996841192994846
MENTAL RETARDATION, X-LINKED 1	0.010531130999999999	0.6857657419243802
IMMUNODEFICIENCY 47	0.010531130999999999	0.6857657419243802
#613150 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 2; MDDGA2;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT2-RELATED	0.010531130999999999	0.6857657419243802
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.010531130999999999	0.6857657419243802
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.010531130999999999	0.6857657419243802
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.010531130999999999	0.6857657419243802
#300534 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, JARID1C-RELATED; MRXSJ	0.010531130999999999	0.6857657419243802
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.010459262	0.6810857794297193
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.010459262	0.6810857794297193
COFFIN-SIRIS SYNDROME 7; CSS7	0.010459262	0.6810857794297193
Mental retardation, autosomal dominant 21	0.010459262	0.6810857794297193
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.010459262	0.6810857794297193
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.010459262	0.6810857794297193
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.010459262	0.6810857794297193
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.010459262	0.6810857794297193
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.010459262	0.6810857794297193
Aarskog-Scott syndrome	0.010459262	0.6810857794297193
JOUBERT SYNDROME 24	0.010459262	0.6810857794297193
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.010459262	0.6810857794297193
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.010092963	0.6572331366792721
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.010092963	0.6572331366792721
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.010092963	0.6572331366792721
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.010092963	0.6572331366792721
Xq28 (MECP2) duplication	0.010092963	0.6572331366792721
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.010092963	0.6572331366792721
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.010092963	0.6572331366792721
#608027 PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3;;CEREBELLAR ATROPHY WITH PROGRESSIVE MICROCEPHALY; CLAM;;PCH WITH OPTIC ATROPHY	0.010092963	0.6572331366792721
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.010092963	0.6572331366792721
#613744 SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 4, FORMERLY; CPSQ4, FORMERLY	0.010092963	0.6572331366792721
#612936 SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3, FORMERLY; CPSQ3, FORMERLY	0.010092963	0.6572331366792721
#300422 FG SYNDROME 4; FGS4MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT NYSTAGMUS, INCLUDED	0.010092963	0.6572331366792721
#218000 AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN;;CHARLEVOIX DISEASE;;ANDERMANN SYNDROME;;POLYNEUROPATHY, SENSORIMOTOR, WITH OR WITHOUT AGENESIS OF THE CORPUSCALLOSUM;;CORPUS CALLOSUM, AGENESIS OF, WITH NEURONOPATHY	0.010092963	0.6572331366792721
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.010092963	0.6572331366792721
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip; CDG1P	0.010092963	0.6572331366792721
#305450 OPITZ-KAVEGGIA SYNDROME; OKS;;FG SYNDROME 1; FGS1;;FG SYNDROME; FGS;;MENTAL RETARDATION, LARGE HEAD, IMPERFORATE ANUS, CONGENITAL HYPOTONIA,AND PARTIAL AGENESIS OF CORPUS CALLOSUM;;KELLER SYNDROME	0.010092963	0.6572331366792721
#613180 POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.010092963	0.6572331366792721
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.010092963	0.6572331366792721
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.00998963	0.6505043027667253
%164900 OPHTHALMOMANDIBULOMELIC DYSPLASIA;;OMM SYNDROME	0.00990099	0.6447322470051764
#174800 MCCUNE-ALBRIGHT SYNDROME; MAS;;ALBRIGHT SYNDROMEPOLYOSTOTIC FIBROUS DYSPLASIA, INCLUDED; PFD, INCLUDED; POFD, INCLUDED	0.00990099	0.6447322470051764
SANDHOFF DISEASE	0.00990099	0.6447322470051764
221810 DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE;;KIRGHIZIAN DERMATOOSTEOLYSIS	0.00990099	0.6447322470051764
THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL RECESSIVE; THPH6	0.00990099	0.6447322470051764
#601553 HYPOTRICHOSIS, CONGENITAL, WITH JUVENILE MACULAR DYSTROPHY; HJMD;;HYPOTRICHOSIS WITH CONE-ROD DYSTROPHY	0.00990099	0.6447322470051764
RETINOPATHY, PERICENTRAL PIGMENTARY, DOMINANT	0.00990099	0.6447322470051764
FREESIA FLOWERS, INABILITY TO SMELL	0.00990099	0.6447322470051764
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00990099	0.6447322470051764
#259710 OSTEOPETROSIS, AUTOSOMAL RECESSIVE 2; OPTB2;;OSTEOPETROSIS, OSTEOCLAST-POOR;;OSTEOPETROSIS, MILD AUTOSOMAL RECESSIVE FORM	0.00990099	0.6447322470051764
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.00990099	0.6447322470051764
RETINITIS PIGMENTOSA 71; RP71	0.00990099	0.6447322470051764
VITREORETINOPATHY, NEOVASCULAR INFLAMMATORY	0.00990099	0.6447322470051764
RODRIGUES BLINDNESS	0.00990099	0.6447322470051764
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00990099	0.6447322470051764
FLECK RETINA, FAMILIAL BENIGN; FRFB	0.00990099	0.6447322470051764
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00990099	0.6447322470051764
NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 3; CSNBAD3	0.00990099	0.6447322470051764
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1D; CSNB1D	0.00990099	0.6447322470051764
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.00990099	0.6447322470051764
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.00990099	0.6447322470051764
LEBER CONGENITAL AMAUROSIS, TYPE I	0.00990099	0.6447322470051764
TEMPORAL ARTERITIS	0.00990099	0.6447322470051764
RETINITIS PIGMENTOSA 29; RP29	0.00990099	0.6447322470051764
WEILL-MARCHESANI SYNDROME 2; WMS2	0.00990099	0.6447322470051764
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.00990099	0.6447322470051764
STICKLER SYNDROME, TYPE I	0.00990099	0.6447322470051764
#148210 KERATITIS-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL DOMINANT;;KID SYNDROME, AUTOSOMAL DOMINANT	0.00990099	0.6447322470051764
RETINITIS PIGMENTOSA 35; RP35	0.00990099	0.6447322470051764
LEBER CONGENITAL AMAUROSIS, TYPE II	0.00990099	0.6447322470051764
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.00990099	0.6447322470051764
EHLERS-DANLOS SYNDROME, TYPE VI	0.00990099	0.6447322470051764
RETINITIS PIGMENTOSA INVERSA WITH DEAFNESS	0.00990099	0.6447322470051764
CEREBRAL SCLEROSIS, DIFFUSE, SCHOLZ TYPE	0.00990099	0.6447322470051764
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1G; CSNB1G	0.00990099	0.6447322470051764
CYSTINOSIS, NEPHROPATHIC; CTNS	0.00990099	0.6447322470051764
VITREORETINOCHOROIDOPATHY; VRCP	0.00990099	0.6447322470051764
#216900 ACHROMATOPSIA 2; ACHM2;;COLORBLINDNESS, TOTAL;;ROD MONOCHROMATISM 2;;ROD MONOCHROMACY 2; RMCH2	0.00990099	0.6447322470051764
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.00990099	0.6447322470051764
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3	0.00990099	0.6447322470051764
CATARACT 11, MULTIPLE TYPES; CTRCT11	0.00990099	0.6447322470051764
PIERSON SYNDROME	0.00990099	0.6447322470051764
FLECK RETINA OF KANDORI	0.00990099	0.6447322470051764
MUSK, INABILITY TO SMELL	0.00990099	0.6447322470051764
PALLIDAL DEGENERATION, PROGRESSIVE, WITH RETINITIS PIGMENTOSA	0.00990099	0.6447322470051764
SORSBY FUNDUS DYSTROPHY; SFD	0.00990099	0.6447322470051764
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.00990099	0.6447322470051764
WEILL-MARCHESANI SYNDROME 1; WMS1	0.00990099	0.6447322470051764
#219000 FRASER SYNDROME;;CRYPTOPHTHALMOS WITH OTHER MALFORMATIONSCRYPTOPHTHALMOS-SYNDACTYLY SYNDROME, INCLUDED	0.00990099	0.6447322470051764
USHER SYNDROME, TYPE IID; USH2D	0.00990099	0.6447322470051764
#184460 STAPES ANKYLOSIS WITH BROAD THUMB AND TOES;;ANKYLOSIS OF STAPES, HYPEROPIA, BROAD THUMBS, BROAD FIRST TOES, ANDSYNDACTYLY;;TEUNISSEN-CREMERS SYNDROME;;STAPES ANKYLOSIS SYNDROME WITHOUT SYMPHALANGISM	0.00961538	0.6261339071354111
#608553 LEBER CONGENITAL AMAUROSIS 9; LCA9	0.00961538	0.6261339071354111
127200 DWARFISM WITH STIFF JOINTS AND OCULAR ABNORMALITIES;;MOORE-FEDERMAN SYNDROME	0.00961538	0.6261339071354111
COLOBOMA OF MACULA AND SKELETAL ANOMALIES	0.00961538	0.6261339071354111
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00961538	0.6261339071354111
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.00961538	0.6261339071354111
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.00961538	0.6261339071354111
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.00961538	0.6261339071354111
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.00961538	0.6261339071354111
BRACHYDACTYLY, TYPE B2	0.00961538	0.6261339071354111
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.00961538	0.6261339071354111
108450 ASYMMETRIC SHORT STATURE SYNDROME	0.00961538	0.6261339071354111
CRANIOECTODERMAL DYSPLASIA 4	0.00961538	0.6261339071354111
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1H; CSNB1H	0.00961538	0.6261339071354111
%153880 MACULAR EDEMA, CYSTOID;;CYSTOID MACULAR DYSTROPHY; CYMD;;MACULAR DYSTROPHY, DOMINANT CYSTOID; MDDC;;DCMD	0.00961538	0.6261339071354111
#217300 CORNEA PLANA 2; CNA2	0.00961538	0.6261339071354111
CORNEAL DYSTROPHY, POSTERIOR AMORPHOUS	0.00961538	0.6261339071354111
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.00961538	0.6261339071354111
PILODENTAL DYSPLASIA WITH REFRACTIVE ERRORS	0.00961538	0.6261339071354111
#613078 NIJMEGEN BREAKAGE SYNDROME-LIKE DISORDER; NBSLD;;NBS-LIKE DISORDER;;RAD50 DEFICIENCY;;MICROCEPHALY AND SPONTANEOUS CHROMOSOME INSTABILITY WITHOUT IMMUNODEFICIENCY	0.00961538	0.6261339071354111
MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA; MSPKA	0.00961538	0.6261339071354111
FLOATING-HARBOR SYNDROME	0.00961538	0.6261339071354111
#113500 BRACHYOLMIA TYPE 3;;BRACHYOLMIA, AUTOSOMAL DOMINANT;;BRACHYRACHIA	0.00961538	0.6261339071354111
PIGMENTED PARAVENOUS CHORIORETINAL ATROPHY	0.00961538	0.6261339071354111
#264470 PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY;;STRAIGHT-CHAIN ACYL-CoA OXIDASE DEFICIENCY;;PSEUDONEONATAL ADRENOLEUKODYSTROPHY	0.009249081	0.6022812643849639
#614399 MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET;EMARDDMYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET,MILD VARIANT, INCLUDED	0.009249081	0.6022812643849639
RETT SYNDROME, CONGENITAL VARIANT	0.009249081	0.6022812643849639
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.009249081	0.6022812643849639
#602541 MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE; MDCMC;;MUSCULAR DYSTROPHY, CONGENITAL, WITH MITOCHONDRIAL STRUCTURAL ABNORMALITIES	0.009249081	0.6022812643849639
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.009249081	0.6022812643849639
#613707 LEOPARD SYNDROME 3; LPRD3	0.009249081	0.6022812643849639
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.009177212	0.5976013018903028
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.009177212	0.5976013018903028
#272200 MULTIPLE SULFATASE DEFICIENCY; MSD;;MUCOSULFATIDOSIS;;SULFATIDOSIS, JUVENILE, AUSTIN TYPE	0.009177212	0.5976013018903028
HARTSFIELD SYNDROME; HRTFDS	0.009177212	0.5976013018903028
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.009177212	0.5976013018903028
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.009177212	0.5976013018903028
ALAZAMI-YUAN SYNDROME	0.009177212	0.5976013018903028
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.009177212	0.5976013018903028
#252500 MUCOLIPIDOSIS II ALPHA/BETA;;MUCOLIPIDOSIS II; ML II;;ML II ALPHA/BETA;;I-CELL DISEASE; ICD	0.009177212	0.5976013018903028
HYPOTONIA-CYSTINURIA SYNDROME	0.009177212	0.5976013018903028
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.009177212	0.5976013018903028
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.008656183	0.5636729575606084
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.008656183	0.5636729575606084
FG SYNDROME 2; FGS2	0.00833333	0.5426494295959946
MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS9	0.00833333	0.5426494295959946
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.00833333	0.5426494295959946
#615715 BONE MARROW FAILURE SYNDROME 2; BMFS2	0.00833333	0.5426494295959946
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00833333	0.5426494295959946
MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL; CMS3A	0.00833333	0.5426494295959946
%300703 SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5	0.00833333	0.5426494295959946
#255320 MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA;;MINICORE MYOPATHY;;MULTICORE MYOPATHY;;MULTIMINICORE MYOPATHY MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA;;MULTIMINICORE DISEASE WITH EXTERNAL OPHTHALMOPLEGIA	0.00833333	0.5426494295959946
139750 HAND AND FOOT DEFORMITY WITH FLAT FACIES	0.00833333	0.5426494295959946
GERMAN SYNDROME	0.00833333	0.5426494295959946
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.00833333	0.5426494295959946
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.00833333	0.5426494295959946
PLEOCONIAL MYOPATHY WITH SALT CRAVING	0.00833333	0.5426494295959946
MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL; CMS4B	0.00833333	0.5426494295959946
IMMUNONEUROLOGIC DISORDER, X-LINKED	0.00833333	0.5426494295959946
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.00833333	0.5426494295959946
BETHLEM MYOPATHY 1	0.00833333	0.5426494295959946
MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	0.00833333	0.5426494295959946
#117000 CENTRAL CORE DISEASE OF MUSCLE;;CCD;;CCOMINICORE MYOPATHY, MODERATE, WITH HAND INVOLVEMENT, INCLUDED;;MULTICORE MYOPATHY, MODERATE, WITH HAND INVOLVEMENT, INCLUDED;;MULTIMINICORE DISEASE, MODERATE, WITH HAND INVOLVEMENT, INCLUDED;;NEUROMUSCULAR DISEASE, CONGENITAL, WITH UNIFORM TYPE 1 FIBER, INCLUDED;CNMDU1, INCLUDED	0.00833333	0.5426494295959946
#310440 MYOPATHY, X-LINKED, WITH EXCESSIVE AUTOPHAGY; MEAX;;XMEA	0.00833333	0.5426494295959946
#168300 PARAMYOTONIA CONGENITA OF VON EULENBURG; PMC;;PARALYSIS PERIODICA PARAMYOTONICAPARAMYOTONIA CONGENITA WITHOUT COLD PARALYSIS, INCLUDED	0.00833333	0.5426494295959946
#255200 MYOPATHY, CENTRONUCLEAR, 2; CNM2;;MYOPATHY, CENTRONUCLEAR, AUTOSOMAL RECESSIVE;;MYOTUBULAR MYOPATHY, AUTOSOMAL RECESSIVE	0.00833333	0.5426494295959946
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8	0.00833333	0.5426494295959946
Ullrich congenital muscular dystrophy 1	0.00833333	0.5426494295959946
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.00833333	0.5426494295959946
NEMALINE MYOPATHY 3; NEM3	0.00833333	0.5426494295959946
#606612 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUTMENTAL RETARDATION), TYPE B, 5; MDDGB5;;MUSCULAR DYSTROPHY, CONGENITAL, 1C; MDC1C;;MUSCULAR DYSTROPHY, CONGENITAL, FKRP-RELATED	0.00833333	0.5426494295959946
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 12; MDDGC12	0.00833333	0.5426494295959946
MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A	0.00833333	0.5426494295959946
MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B	0.00833333	0.5426494295959946
RADICULONEUROPATHY, FATAL NEONATAL	0.00833333	0.5426494295959946
NEUROPATHY, CONGENITAL HYPOMYELINATING, 1, AUTOSOMAL RECESSIVE; CHN1	0.00833333	0.5426494295959946
MYOPATHY, CONGENITAL, COMPTON-NORTH	0.00833333	0.5426494295959946
MUSCULAR DYSTROPHY, CONGENITAL, MEROSIN-POSITIVE	0.00833333	0.5426494295959946
MYASTHENIC SYNDROME, CONGENITAL, 2C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS2C	0.00833333	0.5426494295959946
LOEYS-DIETZ SYNDROME 5	0.00833333	0.5426494295959946
MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	0.00833333	0.5426494295959946
#615595 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 19; COXPD19	0.00833333	0.5426494295959946
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.00833333	0.5426494295959946
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.007932472999999999	0.5165464404668515
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.007932472999999999	0.5165464404668515
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.007932472999999999	0.5165464404668515
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.007932472999999999	0.5165464404668515
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.007932472999999999	0.5165464404668515
HEART AND BRAIN MALFORMATION SYNDROME	0.007932472999999999	0.5165464404668515
COFFIN-SIRIS SYNDROME 2; CSS2	0.007932472999999999	0.5165464404668515
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.007932472999999999	0.5165464404668515
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.007932472999999999	0.5165464404668515
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.007932472999999999	0.5165464404668515
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.007932472999999999	0.5165464404668515
JABERI-ELAHI SYNDROME; JABELS	0.007932472999999999	0.5165464404668515
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.007932472999999999	0.5165464404668515
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.007932472999999999	0.5165464404668515
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.007740432	0.5040411227716391
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.007740432	0.5040411227716391
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.007740432	0.5040411227716391
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.007740432	0.5040411227716391
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.007088591	0.46159456817254335
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.007088591	0.46159456817254335
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.007088591	0.46159456817254335
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.007088591	0.46159456817254335
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.007088591	0.46159456817254335
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.007088591	0.46159456817254335
#611755 LEBER CONGENITAL AMAUROSIS 10; LCA10	0.007088591	0.46159456817254335
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.007088591	0.46159456817254335
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.0070167219999999995	0.4569146056778823
HYPERTRYPTOPHANEMIA; HYPTRP	0.0070167219999999995	0.4569146056778823
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.0070167219999999995	0.4569146056778823
MUCOLIPIDOSIS IV; ML4	0.0070167219999999995	0.4569146056778823
#300257 DANON DISEASE;;VACUOLAR CARDIOMYOPATHY AND MYOPATHY, X-LINKED;;PSEUDOGLYCOGENOSIS II;;ANTOPOL DISEASE;;LYSOSOMAL GLYCOGEN STORAGE DISEASE WITHOUT ACID MALTASE DEFICIENCY,FORMERLY;;GLYCOGEN STORAGE DISEASE IIb; GSD2B, FORMERLY;;GSD IIb, FORMERLY	0.0070167219999999995	0.4569146056778823
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.0070167219999999995	0.4569146056778823
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.0070167219999999995	0.4569146056778823
STARGARDT DISEASE 3; STGD3	0.00689655	0.44908925047733095
#608194 CONE-ROD DYSTROPHY 13; CORD13	0.00689655	0.44908925047733095
FOVEAL HYPOPLASIA 2; FVH2	0.00689655	0.44908925047733095
RETINITIS PIGMENTOSA 51; RP51	0.00689655	0.44908925047733095
RETINITIS PIGMENTOSA WITH OR WITHOUT SITUS INVERSUS	0.00689655	0.44908925047733095
#610024 RETINAL CONE DYSTROPHY 3A; RCD3A;;CONE DYSTROPHY WITH NIGHT BLINDNESS AND SUPERNORMAL ROD RESPONSES,PDE6H-RELATEDACHROMATOPSIA 6, INCLUDED; ACHM6, INCLUDED	0.00689655	0.44908925047733095
EXUDATIVE VITREORETINOPATHY 5; EVR5	0.00689655	0.44908925047733095
RETINAL DYSTROPHY WITH OR WITHOUT EXTRAOCULAR ANOMALIES	0.00689655	0.44908925047733095
CORNEAL DYSTROPHY, MEESMANN	0.00689655	0.44908925047733095
#607541 CORNEAL DYSTROPHY, AVELLINO TYPE; CDA;;ACD;;AVELLINO CORNEAL DYSTROPHY;;COMBINED GRANULAR-LATTICE CORNEAL DYSTROPHY;;GRANULAR CORNEAL DYSTROPHY, TYPE II; CGD2	0.00689655	0.44908925047733095
CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 4; PPCD4	0.00689655	0.44908925047733095
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E	0.00689655	0.44908925047733095
KERATOCONUS 9; KTCN9	0.00689655	0.44908925047733095
MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME; MORMS	0.00689655	0.44908925047733095
HERMANSKY-PUDLAK SYNDROME 5; HPS5	0.00689655	0.44908925047733095
#615420 MYOPIA 22, AUTOSOMAL DOMINANT; MYP22	0.00689655	0.44908925047733095
LEBER CONGENITAL AMAUROSIS 16	0.00689655	0.44908925047733095
RETINITIS PIGMENTOSA 56; RP56	0.00689655	0.44908925047733095
COLOBOMA, OCULAR, AUTOSOMAL RECESSIVE	0.00689655	0.44908925047733095
MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA; MACOM	0.00689655	0.44908925047733095
RETINITIS PIGMENTOSA 77; RP77	0.00689655	0.44908925047733095
CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS	0.00689655	0.44908925047733095
HYPEROSTOSIS CRANIALIS INTERNA; HCIN	0.00689655	0.44908925047733095
RETINAL DYSTROPHY, IRIS COLOBOMA, AND COMEDOGENIC ACNE SYNDROME	0.00689655	0.44908925047733095
NANOPHTHALMOS 4; NNO4	0.00689655	0.44908925047733095
FOCAL DERMAL HYPOPLASIA; FDH	0.00689655	0.44908925047733095
EXUDATIVE VITREORETINOPATHY 3; EVR3	0.00689655	0.44908925047733095
RETINITIS PIGMENTOSA 60; RP60	0.00689655	0.44908925047733095
CONE-ROD DYSTROPHY 21; CORD21	0.00689655	0.44908925047733095
#614076 HERMANSKY-PUDLAK SYNDROME 7; HPS7	0.00689655	0.44908925047733095
COLOBOMA, OCULAR	0.00689655	0.44908925047733095
HERMANSKY-PUDLAK SYNDROME 4; HPS4	0.00689655	0.44908925047733095
ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES; IKSHD	0.00689655	0.44908925047733095
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.00689655	0.44908925047733095
#613270 CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 6; FECD6;;CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, LATE-ONSET	0.00689655	0.44908925047733095
MACULAR DYSTROPHY, VITELLIFORM, 3; VMD3	0.00689655	0.44908925047733095
RETINITIS PIGMENTOSA 85; RP85	0.00689655	0.44908925047733095
#305390 EXUDATIVE VITREORETINOPATHY 2, X-LINKED; EVR2;;EXUDATIVE VITREORETINOPATHY, FAMILIAL, 2;;EVRX;;FEVR, X-LINKED; FEVRX	0.00689655	0.44908925047733095
#613216 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1C; CSNB1C;;CSNB, COMPLETE, AUTOSOMAL RECESSIVE	0.00689655	0.44908925047733095
SENIOR-LOKEN SYNDROME 8; SLSN8	0.00689655	0.44908925047733095
PSEUDOXANTHOMA ELASTICUM; PXE	0.00689655	0.44908925047733095
#300834 MACULAR DEGENERATION, X-LINKED ATROPHIC	0.00689655	0.44908925047733095
#612657 CONE-ROD DYSTROPHY 12; CORD12	0.00689655	0.44908925047733095
ALBINISM, OCULOCUTANEOUS, TYPE VI; OCA6	0.00689655	0.44908925047733095
CONE-ROD DYSTROPHY 5; CORD5	0.00689655	0.44908925047733095
RETINITIS PIGMENTOSA 76; RP76	0.00689655	0.44908925047733095
SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE; SPAX9	0.00689655	0.44908925047733095
ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2	0.00689655	0.44908925047733095
#204870 CORNEAL DYSTROPHY, GELATINOUS DROP-LIKE; GDLD;;CDGDL;;AMYLOIDOSIS, CORNEAL;;AMYLOID CORNEAL DYSTROPHY, JAPANESE TYPE;;CORNEAL DYSTROPHY, LATTICE TYPE III;;LATTICE CORNEAL DYSTROPHY, TYPE III	0.00689655	0.44908925047733095
#613194 RETINITIS PIGMENTOSA 50; RP50RETINITIS PIGMENTOSA, CONCENTRIC, INCLUDED	0.00689655	0.44908925047733095
RETINAL DYSTROPHY AND IRIS COLOBOMA WITH OR WITHOUT CONGENITAL CATARACT	0.00689655	0.44908925047733095
MACULAR DYSTROPHY, PATTERNED, 3; MDPT3	0.00689655	0.44908925047733095
#616118 MACULAR DEGENERATION, EARLY-ONSET; EOMD	0.00689655	0.44908925047733095
INTELLECTUAL DEVELOPMENTAL DISORDER AND RETINITIS PIGMENTOSA; IDDRP	0.00689655	0.44908925047733095
#603786 STARGARDT DISEASE 4; STGD4	0.00689655	0.44908925047733095
N SYNDROME	0.00617284	0.4019627333835741
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00617284	0.4019627333835741
#613268 CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 4; FECD4;;CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, LATE-ONSET	0.00617284	0.4019627333835741
ALBINISM, OCULAR, TYPE I	0.00617284	0.4019627333835741
SPASTIC PARAPLEGIA 16, X-LINKED	0.00617284	0.4019627333835741
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.00617284	0.4019627333835741
#606952 ALBINISM, OCULOCUTANEOUS, TYPE IB; OCA1B;;OCULOCUTANEOUS ALBINISM, TYPE IB;;ALBINISM, YELLOW MUTANT TYPE;;YELLOW ALBINISMALBINISM, OCULOCUTANEOUS, TYPE I, TEMPERATURE-SENSITIVE, INCLUDED;;OCA1-TS, INCLUDED	0.00617284	0.4019627333835741
#604360 SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE; SPG11;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, WITH MENTAL IMPAIRMENT ANDTHIN CORPUS CALLOSUM;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, COMPLICATED, WITH THIN CORPUSCALLOSUM;;HSP-TCC	0.00617284	0.4019627333835741
#606574 ALBINISM, OCULOCUTANEOUS, TYPE IV; OCA4;;OCULOCUTANEOUS ALBINISM, TYPE IV	0.00617284	0.4019627333835741
AUDITORY NEUROPATHY AND OPTIC ATROPHY; ANOA	0.00617284	0.4019627333835741
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6	0.00617284	0.4019627333835741
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00617284	0.4019627333835741
#613856 ACHROMATOPSIA 4; ACHM4	0.00617284	0.4019627333835741
#258450 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS,AUTOSOMAL RECESSIVE; PEOB;;PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL RECESSIVE	0.00617284	0.4019627333835741
#612775 CONE-ROD DYSTROPHY 9; CORD9	0.00617284	0.4019627333835741
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.00617284	0.4019627333835741
AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS	0.00617284	0.4019627333835741
DOYNE HONEYCOMB RETINAL DYSTROPHY	0.00617284	0.4019627333835741
GILLESPIE SYNDROME; GLSP	0.00617284	0.4019627333835741
CHORIORETINAL ATROPHY, PROGRESSIVE BIFOCAL	0.00617284	0.4019627333835741
FOVEAL HYPOPLASIA AND PRESENILE CATARACT SYNDROMEFOVEAL HYPOPLASIA, ISOLATED, INCLUDED	0.00617284	0.4019627333835741
EPITHELIAL RECURRENT EROSION DYSTROPHY	0.00617284	0.4019627333835741
HERMANSKY-PUDLAK SYNDROME 3; HPS3	0.00617284	0.4019627333835741
#607921 RETINITIS PIGMENTOSA 30; RP30	0.00617284	0.4019627333835741
#603649 CONE-ROD DYSTROPHY 7; CORD7	0.00617284	0.4019627333835741
#613829 LEBER CONGENITAL AMAUROSIS 7; LCA7	0.00617284	0.4019627333835741
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00617284	0.4019627333835741
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.00617284	0.4019627333835741
#614180 RETINITIS PIGMENTOSA 61; RP61	0.00617284	0.4019627333835741
XFE PROGEROID SYNDROME; XFEPS	0.00617284	0.4019627333835741
CORNEA GUTTATA WITH ANTERIOR POLAR CATARACTS	0.00617284	0.4019627333835741
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIC, WITH OPTIC ATROPHY; HMSN6C	0.00617284	0.4019627333835741
LEBER CONGENITAL AMAUROSIS 19; LCA19	0.00617284	0.4019627333835741
%258500 OPTIC ATROPHY 6; OPA6;;OPTIC ATROPHY, CONGENITAL OR EARLY INFANTILE, AUTOSOMAL RECESSIVE	0.00617284	0.4019627333835741
#613428 RETINITIS PIGMENTOSA 54; RP54	0.00617284	0.4019627333835741
LEG, ABSENCE DEFORMITY OF, WITH CONGENITAL CATARACT	0.00617284	0.4019627333835741
#613758 RETINITIS PIGMENTOSA 47; RP47	0.00617284	0.4019627333835741
#612390 PONTOCEREBELLAR HYPOPLASIA, TYPE 2C; PCH2C	0.00617284	0.4019627333835741
#613827 RETINITIS PIGMENTOSA 48; RP48	0.00617284	0.4019627333835741
#610427 CONE-ROD SYNAPTIC DISORDER, CONGENITAL NONPROGRESSIVE; CRSD;;NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B, FORMERLY; CSNB2B,FORMERLY;;NIGHT BLINDNESS, CONGENITAL STATIONARY, INCOMPLETE, AUTOSOMAL RECESSIVE,FORMERLY	0.00617284	0.4019627333835741
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00617284	0.4019627333835741
TANGIER DISEASE; TGD	0.00617284	0.4019627333835741
OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALDOMINANT	0.00617284	0.4019627333835741
ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00617284	0.4019627333835741
BIRDSHOT CHORIORETINOPATHY	0.00617284	0.4019627333835741
OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4	0.00617284	0.4019627333835741
DYSKERATOSIS, HEREDITARY BENIGN INTRAEPITHELIAL; HBID	0.00617284	0.4019627333835741
#614504 USHER SYNDROME, TYPE IIIB; USH3B	0.00617284	0.4019627333835741
#610359 RETINITIS PIGMENTOSA 33; RP33	0.00617284	0.4019627333835741
CREUTZFELDT-JAKOB DISEASE; CJD	0.00617284	0.4019627333835741
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.0055764230000000005	0.36312527646642884
#194190 WOLF-HIRSCHHORN SYNDROME; WHS;;CHROMOSOME 4p16.3 DELETION SYNDROME;;PITT-ROGERS-DANKS SYNDROME; PRDS;;PITT SYNDROME	0.0055764230000000005	0.36312527646642884
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.0055764230000000005	0.36312527646642884
#269000 SC PHOCOMELIA SYNDROME;;SC PSEUDOTHALIDOMIDE SYNDROME	0.0055764230000000005	0.36312527646642884
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.0055764230000000005	0.36312527646642884
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K	0.0055764230000000005	0.36312527646642884
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.0055764230000000005	0.36312527646642884
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.0055764230000000005	0.36312527646642884
MACDERMOT-WINTER SYNDROME	0.0055764230000000005	0.36312527646642884
EMANUEL SYNDROME	0.0055764230000000005	0.36312527646642884
#300867 KABUKI SYNDROME 2; KABUK2	0.0055764230000000005	0.36312527646642884
COFFIN-SIRIS SYNDROME 5	0.0055764230000000005	0.36312527646642884
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.0055764230000000005	0.36312527646642884
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.0055764230000000005	0.36312527646642884
AL KAISSI SYNDROME; ALKAS	0.0055764230000000005	0.36312527646642884
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.0055764230000000005	0.36312527646642884
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.0055764230000000005	0.36312527646642884
PETERS-PLUS SYNDROME; PTRPLS	0.0055764230000000005	0.36312527646642884
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.0055764230000000005	0.36312527646642884
#612938 GROWTH RETARDATION, DEVELOPMENTAL DELAY, COARSE FACIES, AND EARLYDEATH; GDFD	0.0055764230000000005	0.36312527646642884
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.0055764230000000005	0.36312527646642884
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.0055764230000000005	0.36312527646642884
PALLISTER-HALL SYNDROME	0.0055764230000000005	0.36312527646642884
BOHRING-OPITZ SYNDROME	0.0055764230000000005	0.36312527646642884
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.0055764230000000005	0.36312527646642884
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.0055764230000000005	0.36312527646642884
CATEL-MANZKE SYNDROME; CATMANS	0.0055764230000000005	0.36312527646642884
AICARDI-GOUTIERES SYNDROME 7	0.0055764230000000005	0.36312527646642884
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.0055764230000000005	0.36312527646642884
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L	0.0055764230000000005	0.36312527646642884
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.0055764230000000005	0.36312527646642884
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.0055764230000000005	0.36312527646642884
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.0055764230000000005	0.36312527646642884
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.0055764230000000005	0.36312527646642884
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.0055764230000000005	0.36312527646642884
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix; CDG1X	0.0055764230000000005	0.36312527646642884
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.0055764230000000005	0.36312527646642884
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.004732541	0.3081734041721206
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.004732541	0.3081734041721206
BRANCHIOOCULOFACIAL SYNDROME	0.004732541	0.3081734041721206
SECKEL SYNDROME 7; SCKL7	0.004732541	0.3081734041721206
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.004732541	0.3081734041721206
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.004732541	0.3081734041721206
MENKES DISEASE	0.004732541	0.3081734041721206
#609060 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1;;HEPATOENCEPHALOPATHY, EARLY FATAL PROGRESSIVE	0.004732541	0.3081734041721206
#244460 KENNY-CAFFEY SYNDROME, TYPE 1; KCS1;;KCS;;KENNY-CAFFEY SYNDROME, AUTOSOMAL RECESSIVE	0.004732541	0.3081734041721206
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.004732541	0.3081734041721206
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.004732541	0.3081734041721206
SECKEL SYNDROME 1; SCKL1	0.004732541	0.3081734041721206
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.004732541	0.3081734041721206
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.004732541	0.3081734041721206
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.004732541	0.3081734041721206
RETINITIS PIGMENTOSA 59; RP59	0.004732541	0.3081734041721206
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E	0.004732541	0.3081734041721206
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.004732541	0.3081734041721206
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.004732541	0.3081734041721206
MARDEN-WALKER SYNDROME	0.004732541	0.3081734041721206
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.004732541	0.3081734041721206
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.004732541	0.3081734041721206
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.004732541	0.3081734041721206
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.004732541	0.3081734041721206
KAPUR-TORIELLO SYNDROME	0.004732541	0.3081734041721206
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.004732541	0.3081734041721206
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.004660672	0.3034934416774595
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.004660672	0.3034934416774595
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.004660672	0.3034934416774595
%300712 CRANIOFACIOSKELETAL SYNDROME	0.004660672	0.3034934416774595
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.004660672	0.3034934416774595
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.004660672	0.3034934416774595
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.004660672	0.3034934416774595
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg; CDG2G	0.004660672	0.3034934416774595
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.004660672	0.3034934416774595
SILVER-RUSSELL SYNDROME; SRS	0.004660672	0.3034934416774595
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.004660672	0.3034934416774595
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.004660672	0.3034934416774595
WARSAW BREAKAGE SYNDROME; WABS	0.004660672	0.3034934416774595
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.004660672	0.3034934416774595
#612626 CHROMOSOME 15q26-qter DELETION SYNDROME;;DRAYER SYNDROME	0.004660672	0.3034934416774595
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.004660672	0.3034934416774595
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.004660672	0.3034934416774595
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.004660672	0.3034934416774595
SAUL-WILSON SYNDROME; SWILS	0.004660672	0.3034934416774595
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.004660672	0.3034934416774595
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.004660672	0.3034934416774595
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.004660672	0.3034934416774595
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.004660672	0.3034934416774595
#610758 CEREBROOCULOFACIOSKELETAL SYNDROME 4; COFS4	0.004660672	0.3034934416774595
LOWRY-MACLEAN SYNDROME	0.004660672	0.3034934416774595
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.004660672	0.3034934416774595
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.004660672	0.3034934416774595
REVESZ SYNDROME	0.004660672	0.3034934416774595
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.004660672	0.3034934416774595
SECKEL SYNDROME 9; SCKL9	0.004660672	0.3034934416774595
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.004660672	0.3034934416774595
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.004660672	0.3034934416774595
#609054 FANCONI ANEMIA, COMPLEMENTATION GROUP J; FANCJ	0.004660672	0.3034934416774595
DESBUQUOIS DYSPLASIA 2; DBQD2	0.004660672	0.3034934416774595
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.004660672	0.3034934416774595
#615665 JOUBERT SYNDROME 22; JBTS22	0.004660672	0.3034934416774595
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.004660672	0.3034934416774595
CHROMOSOME Xq27.3-q28 DUPLICATION SYNDROME	0.004660672	0.3034934416774595
GABRIELE-DE VRIES SYNDROME; GADEVS	0.004660672	0.3034934416774595
#614732 INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIACONGENITA, AND GENITAL ANOMALIES;;IMAGE SYNDROME	0.004660672	0.3034934416774595
RITSCHER-SCHINZEL SYNDROME 1	0.004660672	0.3034934416774595
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.004660672	0.3034934416774595
TARP SYNDROME; TARPS	0.004660672	0.3034934416774595
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.004660672	0.3034934416774595
CHROMOSOME 22q11.2 DELETION SYNDROME, DISTAL	0.004660672	0.3034934416774595
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.004660672	0.3034934416774595
DIAPHANOSPONDYLODYSOSTOSIS	0.004660672	0.3034934416774595
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.004660672	0.3034934416774595
46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS; SERKAL	0.00381679	0.2485415693831513
MECKEL SYNDROME 12; MKS12	0.00381679	0.2485415693831513
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.00381679	0.2485415693831513
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00381679	0.2485415693831513
PYRUVATE KINASE DEFICIENCY OF RED CELLS	0.00381679	0.2485415693831513
TRANSALDOLASE DEFICIENCY	0.00381679	0.2485415693831513
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00381679	0.2485415693831513
#260370 PANCREATIC AGENESIS, CONGENITAL; PAGEN;;PANCREATIC HYPOPLASIA, CONGENITAL	0.00381679	0.2485415693831513
#614815 JOUBERT SYNDROME 18; JBTS18	0.00381679	0.2485415693831513
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00381679	0.2485415693831513
FINGER LOCKING, RECURRENT, WITH INTRAUTERINE GROWTH RETARDATION ANDPROPORTIONATE SHORT STATURE	0.00381679	0.2485415693831513
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.00381679	0.2485415693831513
BARTSOCAS-PAPAS SYNDROME; BPS	0.00381679	0.2485415693831513
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.00381679	0.2485415693831513
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.00381679	0.2485415693831513
RUSSELL-SILVER SYNDROME, X-LINKED	0.00381679	0.2485415693831513
MITCHELL-RILEY SYNDROME; MTCHRS	0.00381679	0.2485415693831513
HEMOCHROMATOSIS, NEONATAL	0.00381679	0.2485415693831513
MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE); MTDPS15	0.00381679	0.2485415693831513
CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 2	0.00381679	0.2485415693831513
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.00381679	0.2485415693831513
#603194 MECKEL SYNDROME, TYPE 2; MKS2;;MECKEL-GRUBER SYNDROME, TYPE 2	0.00381679	0.2485415693831513
DIABETES MELLITUS, TRANSIENT NEONATAL, 1; TNDM1	0.00381679	0.2485415693831513
CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY, AND MICROPHTHALMIA	0.00381679	0.2485415693831513
138920 GRANDDAD SYNDROME;;GROWTH RETARDATION, AGED FACIES, NORMAL DEVELOPMENT, DECREASED SUBCUTANEOUSFAT, AUTOSOMAL DOMINANT INHERITANCE	0.00381679	0.2485415693831513
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.00381679	0.2485415693831513
MEIER-GORLIN SYNDROME 8; MGORS8	0.00381679	0.2485415693831513
VERVERI-BRADY SYNDROME; VERBRAS	0.00381679	0.2485415693831513
HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 4; HNFJ4	0.00381679	0.2485415693831513
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00381679	0.2485415693831513
NEU-LAXOVA SYNDROME 2; NLS2	0.00381679	0.2485415693831513
JOHANSON-BLIZZARD SYNDROME; JBS	0.00381679	0.2485415693831513
IMMUNODEFICIENCY 55; IMD55	0.00381679	0.2485415693831513
#273750 THREE M SYNDROME 1; 3M1;;3@M SYNDROME;;LE MERRER SYNDROME;;DOLICHOSPONDYLIC DYSPLASIA;;GLOOMY FACE SYNDROMEYAKUT SHORT STATURE SYNDROME, INCLUDED	0.00381679	0.2485415693831513
LETHAL CONGENITAL CONTRACTURE SYNDROME 10; LCCS10	0.00381679	0.2485415693831513
#613804 MEIER-GORLIN SYNDROME 4; MGORS4	0.00381679	0.2485415693831513
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	0.00381679	0.2485415693831513
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.00381679	0.2485415693831513
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.00381679	0.2485415693831513
236640 HYDROCEPHALUS WITH ASSOCIATED MALFORMATIONS	0.00381679	0.2485415693831513
NIJMEGEN BREAKAGE SYNDROME	0.00381679	0.2485415693831513
#192350 VATER ASSOCIATIONVACTERL ASSOCIATION, INCLUDED	0.00381679	0.2485415693831513
#610198 3-@METHYLGLUTACONIC ACIDURIA, TYPE V; MGCA5;;CARDIOMYOPATHY, DILATED, WITH ATAXIA; DCMA;;MGA, TYPE V; MGA5	0.00381679	0.2485415693831513
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00381679	0.2485415693831513
LAMBOTTE SYNDROME	0.00381679	0.2485415693831513
BLOOM SYNDROME	0.00381679	0.2485415693831513
ACRORENAL-MANDIBULAR SYNDROME	0.00381679	0.2485415693831513
SECKEL SYNDROME 4	0.00381679	0.2485415693831513
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih; CDG1H	0.00381679	0.2485415693831513
#150250 LARSEN SYNDROME; LRS	0.00381679	0.2485415693831513
#613370 MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 10; MODY10	0.00381679	0.2485415693831513
#253290 MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS;;PTERYGIUM SYNDROME, MULTIPLE, LETHAL TYPE	0.00381679	0.2485415693831513
TRICHOHEPATOENTERIC SYNDROME 1	0.00381679	0.2485415693831513
MEIER-GORLIN SYNDROME 5; MGORS5	0.00381679	0.2485415693831513
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00381679	0.2485415693831513
HYDROLETHALUS SYNDROME 1	0.00381679	0.2485415693831513
MARTINEZ-FRIAS SYNDROME	0.00381679	0.2485415693831513
Trichothiodystrophy 5, nonphotosensitive	0.00381679	0.2485415693831513
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00381679	0.2485415693831513
Mulchandani-Bhoj-Conlin syndrome	0.00381679	0.2485415693831513
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.00381679	0.2485415693831513
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.00381679	0.2485415693831513
SHORT SYNDROME	0.00381679	0.2485415693831513
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00381679	0.2485415693831513
MECKEL SYNDROME, TYPE 1; MKS1	0.00381679	0.2485415693831513
MEIER-GORLIN SYNDROME 3; MGORS3	0.00381679	0.2485415693831513
TRICHOHEPATOENTERIC SYNDROME 2	0.00381679	0.2485415693831513
HOLOPROSENCEPHALY WITH FETAL AKINESIA/HYPOKINESIA SEQUENCE	0.00381679	0.2485415693831513
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.00381679	0.2485415693831513
MECKEL SYNDROME, TYPE 4; MKS4	0.00381679	0.2485415693831513
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00381679	0.2485415693831513
#256520 NEU-LAXOVA SYNDROME; NLS	0.00381679	0.2485415693831513
MEIER-GORLIN SYNDROME 2; MGORS2	0.00381679	0.2485415693831513
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.00381679	0.2485415693831513
MEIER-GORLIN SYNDROME 1; MGORS1	0.00381679	0.2485415693831513
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00381679	0.2485415693831513
DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE	0.00381679	0.2485415693831513
#246200 DONOHUE SYNDROME;;LEPRECHAUNISMINSULIN RECEPTOR, DEFECT IN, INCLUDED	0.00381679	0.2485415693831513
#608747 INSULIN-LIKE GROWTH FACTOR I DEFICIENCY;;IGF1 DEFICIENCY;;GROWTH RETARDATION WITH SENSORINEURAL DEAFNESS AND MENTAL RETARDATION	0.00381679	0.2485415693831513
KBG SYNDROME	0.001759633	0.1145837070832775
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.001759633	0.1145837070832775
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.001759633	0.1145837070832775
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.001759633	0.1145837070832775
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.001759633	0.1145837070832775
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.001759633	0.1145837070832775
TEMPLE-BARAITSER SYNDROME; TMBTS	0.001759633	0.1145837070832775
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001759633	0.1145837070832775
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.001759633	0.1145837070832775
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001759633	0.1145837070832775
#615279 CARDIOFACIOCUTANEOUS SYNDROME 3; CFC3	0.001759633	0.1145837070832775
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.001759633	0.1145837070832775
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.001759633	0.1145837070832775
CHROMOSOME 19p13.13 DELETION SYNDROME	0.001759633	0.1145837070832775
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.001759633	0.1145837070832775
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.001759633	0.1145837070832775
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.001759633	0.1145837070832775
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.001759633	0.1145837070832775
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001759633	0.1145837070832775
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIq; CDG2Q	0.001759633	0.1145837070832775
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.001759633	0.1145837070832775
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.001759633	0.1145837070832775
#614483 PORENCEPHALY 2; POREN2	0.001759633	0.1145837070832775
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.001759633	0.1145837070832775
#613657 D-2-@HYDROXYGLUTARIC ACIDURIA 2;;D2HGA2	0.001759633	0.1145837070832775
CHROMOSOME 22q13 DUPLICATION SYNDROME	0.001759633	0.1145837070832775
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.001759633	0.1145837070832775
#300894 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5; NBIA5;;BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION; BPAN;;STATIC ENCEPHALOPATHY OF CHILDHOOD WITH NEURODEGENERATION IN ADULTHOOD;SENDA	0.001759633	0.1145837070832775
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.001759633	0.1145837070832775
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw; CDG1W	0.001759633	0.1145837070832775
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.001759633	0.1145837070832775
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.001759633	0.1145837070832775
INFANTILE LIVER FAILURE SYNDROME 1	0.001759633	0.1145837070832775
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.001759633	0.1145837070832775
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.001759633	0.1145837070832775
MENTAL RETARDATION, X-LINKED 90	0.001759633	0.1145837070832775
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.001759633	0.1145837070832775
COACH SYNDROME	0.001759633	0.1145837070832775
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.001759633	0.1145837070832775
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.001759633	0.1145837070832775
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.001759633	0.1145837070832775
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.001759633	0.1145837070832775
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A	0.001759633	0.1145837070832775
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.001759633	0.1145837070832775
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.001759633	0.1145837070832775
#207800 ARGININEMIA;;ARGINASE DEFICIENCY;;HYPERARGININEMIA;;ARG1 DEFICIENCY	0.001759633	0.1145837070832775
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.001759633	0.1145837070832775
CHROMOSOME 10Q26 DELETION SYNDROME	0.001759633	0.1145837070832775
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.001759633	0.1145837070832775
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001759633	0.1145837070832775
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.001759633	0.1145837070832775
LUSCAN-LUMISH SYNDROME; LLS	0.001759633	0.1145837070832775
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iy; CDG1Y	0.001759633	0.1145837070832775
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.001759633	0.1145837070832775
Cerebral creatine deficiency syndrome 2	0.001759633	0.1145837070832775
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.001759633	0.1145837070832775
CITRULLINEMIA, CLASSIC	0.001759633	0.1145837070832775
HOLOPROSENCEPHALY 7	0.001759633	0.1145837070832775
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.001759633	0.1145837070832775
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.001759633	0.1145837070832775
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.001759633	0.1145837070832775
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.001759633	0.1145837070832775
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.001759633	0.1145837070832775
HOLOPROSENCEPHALY 1; HPE1	0.001759633	0.1145837070832775
PHACE ASSOCIATION	0.001759633	0.1145837070832775
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.001759633	0.1145837070832775
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.001759633	0.1145837070832775
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.001759633	0.1145837070832775
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.001759633	0.1145837070832775
GLASS SYNDROME	0.001759633	0.1145837070832775
FOLATE MALABSORPTION, HEREDITARY	0.001759633	0.1145837070832775
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.001759633	0.1145837070832775
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.001759633	0.1145837070832775
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.001759633	0.1145837070832775
C SYNDROME	0.001759633	0.1145837070832775
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.001759633	0.1145837070832775
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.001759633	0.1145837070832775
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.001759633	0.1145837070832775
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001759633	0.1145837070832775
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.001759633	0.1145837070832775
MENTAL RETARDATION, X-LINKED 101; MRX101	0.001759633	0.1145837070832775
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.001759633	0.1145837070832775
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.001759633	0.1145837070832775
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.001759633	0.1145837070832775
ARGININOSUCCINIC ACIDURIA	0.001759633	0.1145837070832775
MENTAL RETARDATION, X-LINKED 88	0.001759633	0.1145837070832775
#311250 ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO;;ORNITHINE CARBAMOYLTRANSFERASE DEFICIENCY;;OTC DEFICIENCYVALPROATE SENSITIVITY, INCLUDED	0.001759633	0.1145837070832775
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001759633	0.1145837070832775
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.001759633	0.1145837070832775
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001759633	0.1145837070832775
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.001759633	0.1145837070832775
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.001759633	0.1145837070832775
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.001759633	0.1145837070832775
VICI SYNDROME; VICIS	0.001759633	0.1145837070832775
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.001759633	0.1145837070832775
#602398 DESMOSTEROLOSIS	0.001759633	0.1145837070832775
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.001759633	0.1145837070832775
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.001759633	0.1145837070832775
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.001759633	0.1145837070832775
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.001759633	0.1145837070832775
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.001759633	0.1145837070832775
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.001759633	0.1145837070832775
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.001759633	0.1145837070832775
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001759633	0.1145837070832775
TIMOTHY SYNDROME; TS	0.001759633	0.1145837070832775
#236250 HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATEREDUCTASE ACTIVITY;;METHYLENETETRAHYDROFOLATE REDUCTASE DEFICIENCY;;MTHFR DEFICIENCYMTHFR DEFICIENCY, THERMOLABILE TYPE, INCLUDED	0.001759633	0.1145837070832775
MENTAL RETARDATION, X-LINKED 72	0.001759633	0.1145837070832775
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.001759633	0.1145837070832775
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.001759633	0.1145837070832775
KETOADIPICACIDURIA	0.001759633	0.1145837070832775
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.001759633	0.1145837070832775
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.001759633	0.1145837070832775
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.001759633	0.1145837070832775
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001759633	0.1145837070832775
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.001759633	0.1145837070832775
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.001759633	0.1145837070832775
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.001759633	0.1145837070832775
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.001759633	0.1145837070832775
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.001759633	0.1145837070832775
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.001759633	0.1145837070832775
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.001759633	0.1145837070832775
MENTAL RETARDATION, X-LINKED 91; MRX91	0.001759633	0.1145837070832775
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.001759633	0.1145837070832775
LISSENCEPHALY 8; LIS8	0.001759633	0.1145837070832775
WEAVER SYNDROME	0.001759633	0.1145837070832775
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001759633	0.1145837070832775
#231050 GELEOPHYSIC DYSPLASIA 1; GPHYSD1	0.001759633	0.1145837070832775
CHROMOSOME 2q37 DELETION SYNDROME	0.001759633	0.1145837070832775
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001759633	0.1145837070832775
Pontine tegmental cap dysplasia	0.001759633	0.1145837070832775
WAISMAN SYNDROME; WSMN	0.001759633	0.1145837070832775
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.001759633	0.1145837070832775
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.001759633	0.1145837070832775
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.001759633	0.1145837070832775
MEND SYNDROME; MEND	0.001759633	0.1145837070832775
SULFOCYSTEINURIA	0.001759633	0.1145837070832775
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001759633	0.1145837070832775
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf; CDG2F	0.001759633	0.1145837070832775
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.001759633	0.1145837070832775
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.001759633	0.1145837070832775
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.001759633	0.1145837070832775
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.001759633	0.1145837070832775
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.001759633	0.1145837070832775
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.001759633	0.1145837070832775
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.001759633	0.1145837070832775
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.001759633	0.1145837070832775
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.001759633	0.1145837070832775
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.001759633	0.1145837070832775
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.001759633	0.1145837070832775
LISSENCEPHALY 4	0.001759633	0.1145837070832775
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.001759633	0.1145837070832775
MENTAL RETARDATION, X-LINKED 9	0.001759633	0.1145837070832775
#158350 COWDEN SYNDROME 1; CWS1;;CS; CD;;MULTIPLE HAMARTOMA SYNDROME; MHAMDYSPLASTIC GANGLIOCYTOMA OF THE CEREBELLUM, INCLUDED;;CEREBELLOPARENCHYMAL DISORDER VI, INCLUDED; CPD6, INCLUDED;;CEREBELLAR GRANULE CELL HYPERTROPHY AND MEGALENCEPHALY, INCLUDED;;LHERMITTE-DUCLOS DISEASE, INCLUDED; LDD, INCLUDED;;PROTEUS-LIKE SYNDROME, INCLUDED	0.001759633	0.1145837070832775
CHROMOSOME 5Q12 DELETION SYNDROME	0.001759633	0.1145837070832775
HOLOPROSENCEPHALY 2; HPE2	0.001759633	0.1145837070832775
N-ACETYLASPARTATE DEFICIENCY; NACED	0.001759633	0.1145837070832775
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.001759633	0.1145837070832775
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.001759633	0.1145837070832775
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.001759633	0.1145837070832775
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic; CDG1C	0.001759633	0.1145837070832775
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.001759633	0.1145837070832775
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001759633	0.1145837070832775
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.001759633	0.1145837070832775
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.001759633	0.1145837070832775
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.001759633	0.1145837070832775
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.001759633	0.1145837070832775
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.001759633	0.1145837070832775
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.001759633	0.1145837070832775
#136570 CHROMOSOME 16p12.1 DELETION SYNDROME, 520-KBFRAGILE SITE 16p12, INCLUDED	0.001759633	0.1145837070832775
#610829 HOLOPROSENCEPHALY 9; HPE9;;PITUITARY ANOMALIES WITH HOLOPROSENCEPHALY-LIKE FEATURES;;HOLOPROSENCEPHALY WITH MICROPHTHALMIA AND FIRST BRANCHIAL ARCH ANOMALIES	0.001759633	0.1145837070832775
#612716 DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY;;SEPIAPTERIN REDUCTASE DEFICIENCY;;SPR DEFICIENCY	0.001759633	0.1145837070832775
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.001759633	0.1145837070832775
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001759633	0.1145837070832775
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.001759633	0.1145837070832775
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.001759633	0.1145837070832775
CHROMOSOME 19q13.11 DELETION SYNDROME, PROXIMAL	0.001759633	0.1145837070832775
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.001759633	0.1145837070832775
#243500 ISOVALERIC ACIDEMIA; IVA;;ISOVALERIC ACID CoA DEHYDROGENASE DEFICIENCY;;IVD DEFICIENCY	0.001759633	0.1145837070832775
RECOMBINANT CHROMOSOME 8 SYNDROME	0.001759633	0.1145837070832775
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.001759633	0.1145837070832775
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.001759633	0.1145837070832775
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.001759633	0.1145837070832775
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.001759633	0.1145837070832775
METHYLMALONIC ACIDURIA, CBLA TYPE	0.001759633	0.1145837070832775
HARTNUP DISORDER	0.001759633	0.1145837070832775
CORNELIA DE LANGE SYNDROME 3	0.001759633	0.1145837070832775
#251290 BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA;BLCPMG;;PSEUDO-TORCH SYNDROME	0.001759633	0.1145837070832775
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.001759633	0.1145837070832775
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001759633	0.1145837070832775
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.001759633	0.1145837070832775
ADAMS-OLIVER SYNDROME 1; AOS1	0.001759633	0.1145837070832775
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.001759633	0.1145837070832775
CHROMOSOME 3pter-p25 DELETION SYNDROME	0.001759633	0.1145837070832775
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.001759633	0.1145837070832775
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.001759633	0.1145837070832775
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001759633	0.1145837070832775
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.001759633	0.1145837070832775
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001759633	0.1145837070832775
#614322 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12;;SPINOCEREBELLAR ATAXIA WITH MENTAL RETARDATION AND EPILEPSY	0.001759633	0.1145837070832775
LISSENCEPHALY 1; LIS1	0.001759633	0.1145837070832775
3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD	0.001759633	0.1145837070832775
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.001759633	0.1145837070832775
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.001759633	0.1145837070832775
CHROMOSOME 16p13.3 DELETION SYNDROME	0.001759633	0.1145837070832775
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.001759633	0.1145837070832775
IMMUNODEFICIENCY 49; IMD49	0.001759633	0.1145837070832775
#300831 CK SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH THIN BODY HABITUS AND CORTICALMALFORMATION	0.001759633	0.1145837070832775
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001759633	0.1145837070832775
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.001759633	0.1145837070832775
TEMTAMY SYNDROME; TEMTYS	0.001759633	0.1145837070832775
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.001759633	0.1145837070832775
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu; CDG1U	0.001759633	0.1145837070832775
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.001759633	0.1145837070832775
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.001759633	0.1145837070832775
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.001759633	0.1145837070832775
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.001759633	0.1145837070832775
PETTIGREW SYNDROME	0.001759633	0.1145837070832775
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.001759633	0.1145837070832775
XQ25 DUPLICATION SYNDROME	0.001759633	0.1145837070832775
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.001759633	0.1145837070832775
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001759633	0.1145837070832775
SHUKLA-VERNON SYNDROME; SHUVER	0.001759633	0.1145837070832775
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.001759633	0.1145837070832775
#245400 MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITHMETHYLMALONIC ACIDURIA); MTDPS9;;LACTIC ACIDOSIS, FATAL INFANTILE, FORMERLY	0.001759633	0.1145837070832775
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.001759633	0.1145837070832775
SHASHI-PENA SYNDROME; SHAPNS	0.001759633	0.1145837070832775
SMITH-MAGENIS SYNDROME; SMS	0.001759633	0.1145837070832775
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L	0.001759633	0.1145837070832775
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.001759633	0.1145837070832775
WIEDEMANN-STEINER SYNDROME; WDSTS	0.001759633	0.1145837070832775
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.001759633	0.1145837070832775
611961 STEVENSON-CAREY SYNDROME	0.001759633	0.1145837070832775
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.001759633	0.1145837070832775
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.001759633	0.1145837070832775
#613730 HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION,AND CATARACTS; HDBSCC	0.001759633	0.1145837070832775
GLYCEROL KINASE DEFICIENCY; GKD	0.001759633	0.1145837070832775
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.001759633	0.1145837070832775
GRACILE BONE DYSPLASIA; GCLEB	0.001759633	0.1145837070832775
PELIZAEUS-MERZBACHER DISEASE	0.001759633	0.1145837070832775
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.001759633	0.1145837070832775
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.001759633	0.1145837070832775
#237300 CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO;;CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY;;CPS I DEFICIENCY	0.001759633	0.1145837070832775
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.001759633	0.1145837070832775
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001759633	0.1145837070832775
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.001759633	0.1145837070832775
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.001759633	0.1145837070832775
#606777 GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1;;GLUCOSE TRANSPORT DEFECT, BLOOD-BRAIN BARRIERGLUT1 DEFICIENCY SYNDROME 1, AUTOSOMAL RECESSIVE, INCLUDED	0.001759633	0.1145837070832775
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.001759633	0.1145837070832775
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001759633	0.1145837070832775
#611718 HYPOMAGNESEMIA 4, RENAL; HOMG4;;HYPOMAGNESEMIA, RENAL, NORMOCALCIURIC	0.001759633	0.1145837070832775
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.001759633	0.1145837070832775
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.001759633	0.1145837070832775
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.001759633	0.1145837070832775
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.001759633	0.1145837070832775
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.001759633	0.1145837070832775
BARAITSER-WINTER SYNDROME 1; BRWS1	0.001759633	0.1145837070832775
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.001759633	0.1145837070832775
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001759633	0.1145837070832775
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.001759633	0.1145837070832775
NIEMANN-PICK DISEASE, TYPE C2	0.001759633	0.1145837070832775
#274000 THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR;;TAR SYNDROME;;CHROMOSOME 1q21.1 DELETION SYNDROME, 200-KB	0.001759633	0.1145837070832775
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.001759633	0.1145837070832775
LANDAU-KLEFFNER SYNDROME	0.001759633	0.1145837070832775
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001759633	0.1145837070832775
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.001759633	0.1145837070832775
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.001759633	0.1145837070832775
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.001759633	0.1145837070832775
ELEJALDE DISEASE	0.001759633	0.1145837070832775
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.001759633	0.1145837070832775
CODAS SYNDROME	0.001759633	0.1145837070832775
ANGELMAN SYNDROME	0.001759633	0.1145837070832775
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.001759633	0.1145837070832775
KLEEFSTRA SYNDROME 2; KLEFS2	0.001759633	0.1145837070832775
KABUKI SYNDROME 1	0.001759633	0.1145837070832775
#225750 AICARDI-GOUTIERES SYNDROME 1; AGS1;;AGS;;ENCEPHALOPATHY, FAMILIAL INFANTILE, WITH INTRACRANIAL CALCIFICATIONAND CHRONIC CEREBROSPINAL FLUID LYMPHOCYTOSIS;;CREE ENCEPHALITIS;;PSEUDOTOXOPLASMOSIS SYNDROMEAICARDI-GOUTIERES SYNDROME 1, AUTOSOMAL DOMINANT, INCLUDED	0.001759633	0.1145837070832775
GABA-TRANSAMINASE DEFICIENCY	0.001759633	0.1145837070832775
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.001759633	0.1145837070832775
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.001759633	0.1145837070832775
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.001759633	0.1145837070832775
#300845 MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM,AND FACIAL DYSMORPHISM; MYMY4;;CHROMOSOME XQ28 DELETION SYNDROME, 3.4-KB;;SYNDROMIC MOYAMOYA DISEASE	0.001759633	0.1145837070832775
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001759633	0.1145837070832775
ADAMS-OLIVER SYNDROME 2; AOS2	0.001759633	0.1145837070832775
MENTAL RETARDATION, X-LINKED 103	0.001759633	0.1145837070832775
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.001759633	0.1145837070832775
SALLA DISEASE	0.001759633	0.1145837070832775
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.001759633	0.1145837070832775
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.001759633	0.1145837070832775
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.001759633	0.1145837070832775
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.001759633	0.1145837070832775
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.001759633	0.1145837070832775
MEHMO SYNDROME; MEHMO	0.001759633	0.1145837070832775
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.001759633	0.1145837070832775
Pierpont syndrome	0.001759633	0.1145837070832775
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.001759633	0.1145837070832775
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.001759633	0.1145837070832775
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.001759633	0.1145837070832775
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.001759633	0.1145837070832775
PYRUVATE CARBOXYLASE DEFICIENCY	0.001759633	0.1145837070832775
CHROMOSOME 1q41-q42 DELETION SYNDROME	0.001759633	0.1145837070832775
CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB	0.001759633	0.1145837070832775
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.001759633	0.1145837070832775
BAND HETEROTOPIA; BH	0.001759633	0.1145837070832775
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.001759633	0.1145837070832775
MENTAL RETARDATION, X-LINKED 104; MRX104	0.001759633	0.1145837070832775
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.001759633	0.1145837070832775
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.001759633	0.1145837070832775
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.001759633	0.1145837070832775
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001759633	0.1145837070832775
#300886 MENTAL RETARDATION, X-LINKED, SYNDROMIC 32; MRXS32	0.001759633	0.1145837070832775
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.001759633	0.1145837070832775
#604317 MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICALMALFORMATIONS; MCPH2	0.001759633	0.1145837070832775
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.001759633	0.1145837070832775
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001759633	0.1145837070832775
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.001759633	0.1145837070832775
#614202 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15; MRT15	0.001759633	0.1145837070832775
GRISCELLI SYNDROME, TYPE 1	0.001759633	0.1145837070832775
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.001759633	0.1145837070832775
3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.001759633	0.1145837070832775
WARBURG MICRO SYNDROME 3; WARBM3	0.000915751	0.059631834788969315
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000915751	0.059631834788969315
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.000915751	0.059631834788969315
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.000915751	0.059631834788969315
PARIETAL FORAMINA	0.000915751	0.059631834788969315
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000915751	0.059631834788969315
CROME SYNDROME	0.000915751	0.059631834788969315
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.000915751	0.059631834788969315
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.000915751	0.059631834788969315
POTOCKI-SHAFFER SYNDROME	0.000915751	0.059631834788969315
FOUNTAIN SYNDROME	0.000915751	0.059631834788969315
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000915751	0.059631834788969315
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.000915751	0.059631834788969315
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.000915751	0.059631834788969315
OCULODENTODIGITAL DYSPLASIA; ODDD	0.000915751	0.059631834788969315
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000915751	0.059631834788969315
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.000915751	0.059631834788969315
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.000915751	0.059631834788969315
MAPLE SYRUP URINE DISEASE; MSUD	0.000915751	0.059631834788969315
#215100 RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1;;PEROXISOME BIOGENESIS DISORDER 9; PBD9;;CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC FORM; CDPR;;CHONDRODYSTROPHIA CALCIFICANS PUNCTATA	0.000915751	0.059631834788969315
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.000915751	0.059631834788969315
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.000915751	0.059631834788969315
INFANTILE LIVER FAILURE SYNDROME 2	0.000915751	0.059631834788969315
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000915751	0.059631834788969315
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.000915751	0.059631834788969315
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000915751	0.059631834788969315
#615937 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 2;MPPH2	0.000915751	0.059631834788969315
#276710 TYROSINEMIA, TYPE III; TYRSN3;;4-@HYDROXYPHENYLPYRUVIC ACID OXIDASE DEFICIENCY;;4-@HYDROXYPHENYLPYRUVATE DIOXYGENASE DEFICIENCY	0.000915751	0.059631834788969315
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.000915751	0.059631834788969315
#208900 ATAXIA-TELANGIECTASIA; AT;;AT1;;LOUIS-BAR SYNDROMEAT, COMPLEMENTATION GROUP A, INCLUDED; ATA, INCLUDED;;AT, COMPLEMENTATION GROUP C, INCLUDED; ATC, INCLUDED;;AT, COMPLEMENTATION GROUP D, INCLUDED; ATD, INCLUDED;;AT, COMPLEMENTATION GROUP E, INCLUDED; ATE, INCLUDED;;ATAXIA-TELANGIECTASIA VARIANT, INCLUDED	0.000915751	0.059631834788969315
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.000915751	0.059631834788969315
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000915751	0.059631834788969315
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.000915751	0.059631834788969315
COPPER DEFICIENCY, FAMILIAL BENIGN	0.000915751	0.059631834788969315
#300558 MENTAL RETARDATION, X-LINKED 30; MRX30;;MENTAL RETARDATION, X-LINKED 47; MRX47	0.000915751	0.059631834788969315
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000915751	0.059631834788969315
PALLISTER-KILLIAN SYNDROME	0.000915751	0.059631834788969315
LISSENCEPHALY, X-LINKED, 1; LISX1	0.000915751	0.059631834788969315
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000915751	0.059631834788969315
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.000915751	0.059631834788969315
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.000915751	0.059631834788969315
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000915751	0.059631834788969315
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.000915751	0.059631834788969315
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000915751	0.059631834788969315
EPILEPSY-TELANGIECTASIA	0.000915751	0.059631834788969315
ZUNICH NEUROECTODERMAL SYNDROME	0.000915751	0.059631834788969315
STURGE-WEBER SYNDROME	0.000915751	0.059631834788969315
ACTH DEFICIENCY, ISOLATED; IAD	0.000915751	0.059631834788969315
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.000915751	0.059631834788969315
ACROCALLOSAL SYNDROME; ACLS	0.000915751	0.059631834788969315
#300607 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 8; EIEE8;;HYPEREKPLEXIA AND EPILEPSY	0.000915751	0.059631834788969315
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.000915751	0.059631834788969315
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000915751	0.059631834788969315
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000915751	0.059631834788969315
#222300 WOLFRAM SYNDROME 1; WFS1;;WFS;;DIABETES INSIPIDUS AND MELLITUS WITH OPTIC ATROPHY AND DEAFNESS; DIDMOAD	0.000915751	0.059631834788969315
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.000915751	0.059631834788969315
#235400 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1; AHUS1;;AHUS, SUSCEPTIBILITY TO, 1HEMOLYTIC UREMIC SYNDROME, TYPICAL, INCLUDED	0.000915751	0.059631834788969315
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.000915751	0.059631834788969315
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000915751	0.059631834788969315
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000915751	0.059631834788969315
#309801 MICROPHTHALMIA, SYNDROMIC 7; MCOPS7;;MICROPHTHALMIA WITH LINEAR SKIN DEFECTS; MLS;;MICROPHTHALMIA, DERMAL APLASIA, AND SCLEROCORNEA;;MIDAS SYNDROME	0.000915751	0.059631834788969315
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.000915751	0.059631834788969315
PSEUDO-TORCH SYNDROME 2	0.000915751	0.059631834788969315
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000915751	0.059631834788969315
GITELMAN SYNDROME	0.000915751	0.059631834788969315
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000915751	0.059631834788969315
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.000915751	0.059631834788969315
AUTISM	0.000915751	0.059631834788969315
Angelman syndrome (Type 2)	0.000915751	0.059631834788969315
#300049 HETEROTOPIA, PERIVENTRICULAR, X-LINKED DOMINANT;;HETEROTOPIA, FAMILIAL NODULAR;;PERIVENTRICULAR NODULAR HETEROTOPIA 1; PVNH1;;NODULAR HETEROTOPIA, BILATERAL PERIVENTRICULAR; NHBP; BPNHHETEROTOPIA, PERIVENTRICULAR NODULAR, WITH FRONTOMETAPHYSEAL DYSPLASIA,INCLUDED	0.000915751	0.059631834788969315
#612580 MENTAL RETARDATION, AUTOSOMAL DOMINANT 3; MRD3	0.000915751	0.059631834788969315
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000915751	0.059631834788969315
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000915751	0.059631834788969315
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.000915751	0.059631834788969315
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000915751	0.059631834788969315
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000915751	0.059631834788969315
#236600 HYDROCEPHALUS, NONSYNDROMIC, AUTOSOMAL RECESSIVE 1; HYC1;;HYDROCEPHALY;;VENTRICULOMEGALY	0.000915751	0.059631834788969315
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.000915751	0.059631834788969315
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000915751	0.059631834788969315
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.000915751	0.059631834788969315
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000915751	0.059631834788969315
#614923 BRANCHED-CHAIN KETOACID DEHYDROGENASE KINASE DEFICIENCY; BCKDKD;;BCKDK DEFICIENCY	0.000915751	0.059631834788969315
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000915751	0.059631834788969315
HUNTINGTON DISEASE; HD	0.000915751	0.059631834788969315
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.000915751	0.059631834788969315
HYPOPARATHYROIDISM, X-LINKED	0.000915751	0.059631834788969315
PERRAULT SYNDROME 5; PRLTS5	0.000915751	0.059631834788969315
#141500 MIGRAINE, FAMILIAL HEMIPLEGIC, 1; FHM1;;FHM;;MHP1MIGRAINE, FAMILIAL HEMIPLEGIC 1, WITH PROGRESSIVE CEREBELLAR ATAXIA,INCLUDED;;MIGRAINE, SPORADIC HEMIPLEGIC, INCLUDED	0.000915751	0.059631834788969315
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000915751	0.059631834788969315
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000915751	0.059631834788969315
#177980 PTERYGIA, MENTAL RETARDATION, AND DISTINCTIVE CRANIOFACIAL FEATURES;;HASPESLAGH SYNDROME	0.000915751	0.059631834788969315
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000915751	0.059631834788969315
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000915751	0.059631834788969315
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000915751	0.059631834788969315
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.000915751	0.059631834788969315
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.000915751	0.059631834788969315
#607136 SPINOCEREBELLAR ATAXIA 17; SCA17;;HUNTINGTON DISEASE-LIKE 4; HDL4	0.000915751	0.059631834788969315
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.000915751	0.059631834788969315
#218600 BALLER-GEROLD SYNDROME; BGS;;CRANIOSYNOSTOSIS WITH RADIAL DEFECTS;;CRANIOSYNOSTOSIS-RADIAL APLASIA SYNDROME	0.000915751	0.059631834788969315
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000915751	0.059631834788969315
#614650 COENZYME Q10 DEFICIENCY, PRIMARY, 6; COQ10D6	0.000915751	0.059631834788969315
#604213 CHUDLEY-MCCULLOUGH SYNDROME; CMCS;;DEAFNESS, SENSORINEURAL, WITH PARTIAL AGENESIS OF THE CORPUS CALLOSUMAND ARACHNOID CYSTS;;DEAFNESS, AUTOSOMAL RECESSIVE 82; DFNB82	0.000915751	0.059631834788969315
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.000915751	0.059631834788969315
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000915751	0.059631834788969315
KIFAFA SEIZURE DISORDER	0.000915751	0.059631834788969315
ATKIN-FLAITZ SYNDROME	0.000915751	0.059631834788969315
#229600 FRUCTOSE INTOLERANCE, HEREDITARY;;FRUCTOSEMIA;;FRUCTOSE-1-PHOSPHATE ALDOLASE DEFICIENCY;;FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE B DEFICIENCY;;ALDOLASE B DEFICIENCY;;ALDOB DEFICIENCY	0.000915751	0.059631834788969315
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.000915751	0.059631834788969315
CEREBELLOPARENCHYMAL DISORDER II	0.000915751	0.059631834788969315
CHROMOSOME 15q11-q13 DUPLICATION SYNDROME	0.000915751	0.059631834788969315
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.000915751	0.059631834788969315
GURRIERI SYNDROME	0.000915751	0.059631834788969315
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000915751	0.059631834788969315
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.000915751	0.059631834788969315
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.000915751	0.059631834788969315
ICHTHYOSIS AND MALE HYPOGONADISM	0.000915751	0.059631834788969315
GLUTARIC ACIDEMIA I; GA1	0.000915751	0.059631834788969315
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.000915751	0.059631834788969315
THREONINEMIA	0.000915751	0.059631834788969315
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.000915751	0.059631834788969315
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000915751	0.059631834788969315
HYPOMAGNESEMIA 2, RENAL	0.000915751	0.059631834788969315
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.000915751	0.059631834788969315
#612951 LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY	0.000915751	0.059631834788969315
DARIER-WHITE DISEASE; DAR	0.000915751	0.059631834788969315
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.000915751	0.059631834788969315
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000915751	0.059631834788969315
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.000915751	0.059631834788969315
2q33.1 deletion syndrome	0.000915751	0.059631834788969315
LISSENCEPHALY 5; LIS5	0.000915751	0.059631834788969315
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000915751	0.059631834788969315
#615663 WARBURG MICRO SYNDROME 4; WARBM4	0.000915751	0.059631834788969315
ADAMS-OLIVER SYNDROME 5; AOS5	0.000915751	0.059631834788969315
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000915751	0.059631834788969315
OCULOCEREBROCUTANEOUS SYNDROME	0.000915751	0.059631834788969315
NOONAN SYNDROME 7; NS7	0.000915751	0.059631834788969315
ALZHEIMER DISEASE 3; AD	0.000915751	0.059631834788969315
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000915751	0.059631834788969315
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.000915751	0.059631834788969315
#612475 CHROMOSOME 1q21.1 DUPLICATION SYNDROME	0.000915751	0.059631834788969315
#230000 FUCOSIDOSIS;;ALPHA-L-FUCOSIDASE DEFICIENCY	0.000915751	0.059631834788969315
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000915751	0.059631834788969315
PAPILLORENAL SYNDROME	0.000915751	0.059631834788969315
#128200 EPISODIC KINESIGENIC DYSKINESIA 1; EKD1;;PAROXYSMAL KINESIGENIC CHOREOATHETOSIS; PKC;;PAROXYSMAL KINESIGENIC DYSKINESIA; PKD;;DYSTONIA, FAMILIAL PAROXYSMAL;;DYSTONIA 10; DYT10	0.000915751	0.059631834788969315
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000915751	0.059631834788969315
IMMUNODEFICIENCY 37; IMD37	0.000915751	0.059631834788969315
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000915751	0.059631834788969315
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.000915751	0.059631834788969315
COFFIN-SIRIS SYNDROME 8; CSS8	0.000915751	0.059631834788969315
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.000915751	0.059631834788969315
KLEEFSTRA SYNDROME	0.000915751	0.059631834788969315
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.000915751	0.059631834788969315
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.000915751	0.059631834788969315
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.000915751	0.059631834788969315
PAPILLOMA OF CHOROID PLEXUS	0.000915751	0.059631834788969315
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.000915751	0.059631834788969315
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.000915751	0.059631834788969315
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.000915751	0.059631834788969315
ALEXANDER DISEASE	0.000915751	0.059631834788969315
#103580 PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A;;PHP IA;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITH MULTIPLE HORMONE RESISTANCE	0.000915751	0.059631834788969315
#608033 ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3; IIAE3;;ENCEPHALOPATHY, ACUTE NECROTIZING, SUSCEPTIBILITY TO; ANE	0.000915751	0.059631834788969315
#252940 MUCOPOLYSACCHARIDOSIS, TYPE IIID; MPS3D;;MPS IIID;;SANFILIPPO SYNDROME D;;N-ACETYLGLUCOSAMINE-6-SULFATASE DEFICIENCY	0.000915751	0.059631834788969315
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000915751	0.059631834788969315
#236792 L-2-HYDROXYGLUTARIC ACIDURIA;;L-2-HYDROXYGLUTARIC ACIDEMIA	0.000915751	0.059631834788969315
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000915751	0.059631834788969315
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.000915751	0.059631834788969315
AUTISM, SUSCEPTIBILITY TO, 18	0.000915751	0.059631834788969315
#223360 DOPAMINE BETA-HYDROXYLASE DEFICIENCY, CONGENITAL;;NOREPINEPHRINE DEFICIENCY;;NORADRENALINE DEFICIENCY	0.000915751	0.059631834788969315
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000915751	0.059631834788969315
#187300 TELANGIECTASIA, HEREDITARY HEMORRHAGIC, OF RENDU, OSLER, AND WEBER;HHT;;OSLER-RENDU-WEBER DISEASE;;ORW DISEASETELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 1, INCLUDED; HHT1, INCLUDED	0.000915751	0.059631834788969315
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000915751	0.059631834788969315
LISSENCEPHALY, X-LINKED, 2	0.000915751	0.059631834788969315
EPILEPSY, READING	0.000915751	0.059631834788969315
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000915751	0.059631834788969315
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000915751	0.059631834788969315
#603285 CEREBRAL CAVERNOUS MALFORMATIONS 3; CCM3	0.000915751	0.059631834788969315
ZIMMERMANN-LABAND SYNDROME 1	0.000915751	0.059631834788969315
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000915751	0.059631834788969315
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.000915751	0.059631834788969315
LISSENCEPHALY 3; LIS3	0.000915751	0.059631834788969315
#603516 SPINOCEREBELLAR ATAXIA 10; SCA10	0.000915751	0.059631834788969315
PHENYLKETONURIA	0.000915751	0.059631834788969315
#604004 MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1; MLC1;;VACUOLATING MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS;;LVM;;VL;;LEUKOENCEPHALOPATHY WITH SWELLING AND CYSTS;;VAN DER KNAAP DISEASE	0.000915751	0.059631834788969315
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000915751	0.059631834788969315
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000915751	0.059631834788969315
GLYCINE ENCEPHALOPATHY; GCE	0.000915751	0.059631834788969315
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.000915751	0.059631834788969315
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000915751	0.059631834788969315
#252930 MUCOPOLYSACCHARIDOSIS TYPE IIIC;;MPS IIIC; MPS3C;;SANFILIPPO SYNDROME C;;ACETYL-CoA:ALPHA-GLUCOSAMINIDE N-ACETYLTRANSFERASE DEFICIENCY	0.000915751	0.059631834788969315
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000915751	0.059631834788969315
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000915751	0.059631834788969315
HYPOPHOSPHATASIA, CHILDHOOD	0.000915751	0.059631834788969315
SJOGREN-LARSSON SYNDROME; SLS	0.000915751	0.059631834788969315
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.000915751	0.059631834788969315
INCONTINENTIA PIGMENTI; IP	0.000915751	0.059631834788969315
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.000915751	0.059631834788969315
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000915751	0.059631834788969315
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.000915751	0.059631834788969315
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000915751	0.059631834788969315
HHHH SYNDROME	0.000915751	0.059631834788969315
METACHROMATIC LEUKODYSTROPHY	0.000915751	0.059631834788969315
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000915751	0.059631834788969315
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000915751	0.059631834788969315
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000915751	0.059631834788969315
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000915751	0.059631834788969315
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.000915751	0.059631834788969315
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.000915751	0.059631834788969315
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.000915751	0.059631834788969315
FLYNN-AIRD SYNDROME	0.000915751	0.059631834788969315
GAUCHER DISEASE, TYPE IIIC	0.000915751	0.059631834788969315
CLARK-BARAITSER SYNDROME	0.000915751	0.059631834788969315
#300860 MENTAL RETARDATION, X-LINKED, SYNDROMIC, NASCIMENTO TYPE; MRXSN;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 30; MRXS30	0.000915751	0.059631834788969315
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.000915751	0.059631834788969315
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.000915751	0.059631834788969315
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.000915751	0.059631834788969315
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000915751	0.059631834788969315
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.000915751	0.059631834788969315
VISCERAL STEATOSIS, CONGENITAL	0.000915751	0.059631834788969315
#300143 MENTAL RETARDATION, X-LINKED 21; MRX21;;MENTAL RETARDATION, X-LINKED 34; MRX34	0.000915751	0.059631834788969315
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj; CDG2J	0.000915751	0.059631834788969315
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.000915751	0.059631834788969315
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.000915751	0.059631834788969315
#222748 DIHYDROPYRIMIDINASE DEFICIENCY;;DIHYDROPYRIMIDINURIA;;DPYS DEFICIENCY;;DPH DEFICIENCY	0.000915751	0.059631834788969315
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.000915751	0.059631834788969315
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.000915751	0.059631834788969315
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.000915751	0.059631834788969315
HYPERLYSINEMIA, TYPE I	0.000915751	0.059631834788969315
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.000915751	0.059631834788969315
GLUTATHIONE SYNTHETASE DEFICIENCY	0.000915751	0.059631834788969315
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000915751	0.059631834788969315
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.000915751	0.059631834788969315
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.000915751	0.059631834788969315
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.000915751	0.059631834788969315
COWDEN SYNDROME 5; CWS5	0.000915751	0.059631834788969315
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000915751	0.059631834788969315
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.000915751	0.059631834788969315
MENTAL RETARDATION, X-LINKED 102	0.000915751	0.059631834788969315
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.000915751	0.059631834788969315
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000915751	0.059631834788969315
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000915751	0.059631834788969315
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.000915751	0.059631834788969315
SUDDEN CARDIAC FAILURE, INFANTILE	0.000915751	0.059631834788969315
#612462 PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C;;PHP IC	0.000915751	0.059631834788969315
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000915751	0.059631834788969315
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.000915751	0.059631834788969315
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.000915751	0.059631834788969315
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000915751	0.059631834788969315
ASPARTYLGLUCOSAMINURIA; AGU	0.000915751	0.059631834788969315
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.000915751	0.059631834788969315
EPILEPSY, BENIGN OCCIPITAL	0.000915751	0.059631834788969315
HYPER-BETA-ALANINEMIA	0.000915751	0.059631834788969315
MENTAL RETARDATION, FRA12A TYPE	0.000915751	0.059631834788969315
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000915751	0.059631834788969315
HYPERLEUCINE-ISOLEUCINEMIA	0.000915751	0.059631834788969315
KEARNS-SAYRE SYNDROME; KSS	0.000915751	0.059631834788969315
SUPRABULBAR PARESIS, CONGENITAL	0.000915751	0.059631834788969315
SNEDDON SYNDROME	0.000915751	0.059631834788969315
CHROMOSOME 18Q DELETION SYNDROME	0.000915751	0.059631834788969315
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A	0.000915751	0.059631834788969315
#300337 HYPOMELANOSIS OF ITO; HMI;;INCONTINENTIA PIGMENTI ACHROMIANS; IPA;;ITO HYPOMELANOSIS; ITO;;INCONTINENTIA PIGMENTI, TYPE I, FORMERLY; IP1, FORMERLY	0.000915751	0.059631834788969315
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.000915751	0.059631834788969315
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000915751	0.059631834788969315
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000915751	0.059631834788969315
OROFACIODIGITAL SYNDROME I; OFD1	0.000915751	0.059631834788969315
NEUROFIBROMATOSIS, TYPE II	0.000915751	0.059631834788969315
SMITH-KINGSMORE SYNDROME; SKS	0.000915751	0.059631834788969315
15q13.3 microdeletion syndrome	0.000915751	0.059631834788969315
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000915751	0.059631834788969315
#200150 CHOREOACANTHOCYTOSIS; CHAC;;LEVINE-CRITCHLEY SYNDROME;;ACANTHOCYTOSIS WITH NEUROLOGIC DISORDER;;NEUROACANTHOCYTOSIS;;CHOREA-ACANTHOCYTOSIS	0.000915751	0.059631834788969315
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000915751	0.059631834788969315
BARAITSER-WINTER SYNDROME 2; BRWS2	0.000915751	0.059631834788969315
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.000915751	0.059631834788969315
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000915751	0.059631834788969315
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.000915751	0.059631834788969315
224250 DYSMYELINATION WITH JAUNDICE	0.000915751	0.059631834788969315
#176000 PORPHYRIA, ACUTE INTERMITTENT;;AIP;;PORPHYRIA, SWEDISH TYPE;;PORPHOBILINOGEN DEAMINASE DEFICIENCY;;PBGD DEFICIENCY;;UROPORPHYRINOGEN SYNTHASE DEFICIENCY;;UPS DEFICIENCYPORPHYRIA, ACUTE INTERMITTENT, NONERYTHROID VARIANT, INCLUDED;;PORPHYRIA, CHESTER TYPE, INCLUDED; PORC, INCLUDED	0.000915751	0.059631834788969315
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.000915751	0.059631834788969315
MECKEL SYNDROME, TYPE 10; MKS10	0.000915751	0.059631834788969315
#158900 FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1; FSHD1;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1;;FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FSHD; FMD;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1A; FSHD1A;;LANDOUZY-DEJERINE MUSCULAR DYSTROPHYFACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY, INFANTILE, INCLUDED;;FACIOSCAPULOHUMERAL DYSTROPHY WITH SENSORINEURAL HEARING LOSS ANDTORTUOSITY OF RETINAL ARTERIOLES, INCLUDED	0.000915751	0.059631834788969315
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.000915751	0.059631834788969315
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.000915751	0.059631834788969315
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000915751	0.059631834788969315
#615752 POLYMICROGYRIA, BILATERAL PERISYLVIAN, AUTOSOMAL RECESSIVE; BPPR ;;PMGR	0.000915751	0.059631834788969315
#202200 GLUCOCORTICOID DEFICIENCY 1; GCCD1;;FAMILIAL GLUCOCORTICOID DEFICIENCY 1; FGD1;;ADRENAL UNRESPONSIVENESS TO ACTH;;ACTH RESISTANCE	0.000915751	0.059631834788969315
#605375 EPILEPSY, NOCTURNAL FRONTAL LOBE, 3; ENFL3	0.000915751	0.059631834788969315
GRISCELLI SYNDROME, TYPE 2; GS2	0.000915751	0.059631834788969315
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000915751	0.059631834788969315
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.000915751	0.059631834788969315
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000915751	0.059631834788969315
#309520 LUJAN-FRYNS SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH MARFANOID HABITUS	0.000915751	0.059631834788969315
OHDO SYNDROME	0.000915751	0.059631834788969315
AYME-GRIPP SYNDROME; AYGRP	0.000915751	0.059631834788969315
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000915751	0.059631834788969315
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.000915751	0.059631834788969315
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.000915751	0.059631834788969315
KEUTEL SYNDROME; KTLS	0.000915751	0.059631834788969315
LATHOSTEROLOSIS	0.000915751	0.059631834788969315
SPINOCEREBELLAR ATAXIA 47; SCA47	0.000915751	0.059631834788969315
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.000915751	0.059631834788969315
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000915751	0.059631834788969315
#615705 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 15; SCAR15;;SALIH ATAXIA	0.000915751	0.059631834788969315
Fabry disease	0.000915751	0.059631834788969315
#119540 CLEFT PALATE, ISOLATED; CPI;;CLEFT PALATE; CPCLEFT PALATE, ISOLATED, AND MENTAL RETARDATION, INCLUDED	0.000915751	0.059631834788969315
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000915751	0.059631834788969315
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.000915751	0.059631834788969315
Wolf-Hirschhorn Syndrome	0.000915751	0.059631834788969315
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.000915751	0.059631834788969315
1p36 microdeletion syndrome	0.000915751	0.059631834788969315
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000915751	0.059631834788969315
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000915751	0.059631834788969315
Angelman syndrome (Type 1)	0.000915751	0.059631834788969315
PACHYGYRIA, FRONTOTEMPORAL	0.000915751	0.059631834788969315
#610539 GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY	0.000915751	0.059631834788969315
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.000915751	0.059631834788969315
311450 PALLISTER W SYNDROME;;W SYNDROME	0.000915751	0.059631834788969315
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000915751	0.059631834788969315
COWDEN SYNDROME 6; CWS6	0.000915751	0.059631834788969315
GAPO SYNDROME; GAPOS	0.000915751	0.059631834788969315
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000915751	0.059631834788969315
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.000915751	0.059631834788969315
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000915751	0.059631834788969315
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.000915751	0.059631834788969315
MENTAL RETARDATION, X-LINKED 82	0.000915751	0.059631834788969315
PERRAULT SYNDROME 3	0.000915751	0.059631834788969315
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000915751	0.059631834788969315
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000915751	0.059631834788969315
MENTAL RETARDATION, X-LINKED 100	0.000915751	0.059631834788969315
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.000915751	0.059631834788969315
RAMON SYNDROME	0.000915751	0.059631834788969315
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.000915751	0.059631834788969315
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.000915751	0.059631834788969315
#116860 CEREBRAL CAVERNOUS MALFORMATIONS; CCM;;CAVERNOUS ANGIOMA, FAMILIAL;;CAVERNOUS ANGIOMATOUS MALFORMATIONS; CAM;;CEREBRAL CAPILLARY MALFORMATIONSCEREBRAL CAVERNOUS MALFORMATIONS 1, INCLUDED; CCM1, INCLUDED;;CAVERNOUS MALFORMATIONS OF CNS AND RETINA, INCLUDED;;HYPERKERATOTIC CUTANEOUS CAPILLARY-VENOUS MALFORMATIONS ASSOCIATEDWITH CEREBRAL CAPILLARY MALFORMATIONS, INCLUDED	0.000915751	0.059631834788969315
#240900 HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY; HIHGHH	0.000915751	0.059631834788969315
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.000915751	0.059631834788969315
DIAMINOPENTANURIA	0.000915751	0.059631834788969315
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.000915751	0.059631834788969315
KUFOR-RAKEB SYNDROME	0.000915751	0.059631834788969315
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000915751	0.059631834788969315
THYROCEREBRORETINAL SYNDROME	0.000915751	0.059631834788969315
COFFIN-LOWRY SYNDROME; CLS	0.000915751	0.059631834788969315
MENTAL RETARDATION, X-LINKED 14	0.000915751	0.059631834788969315
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.000915751	0.059631834788969315
EPISODIC ATAXIA, TYPE 6	0.000915751	0.059631834788969315
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.000915751	0.059631834788969315
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000915751	0.059631834788969315
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000915751	0.059631834788969315
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.000915751	0.059631834788969315
FRYNS SYNDROME; FRNS	0.000915751	0.059631834788969315
#309510 PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME; PRTS;;PARTINGTON SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 1; MRXS1;;MENTAL RETARDATION, X-LINKED, WITH DYSTONIC MOVEMENTS, ATAXIA, ANDSEIZURES;;MENTAL RETARDATION, X-LINKED 36; MRX36	0.000915751	0.059631834788969315
CHROMOSOME 15q13.3 MICRODELETION SYNDROME	0.000915751	0.059631834788969315
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.000915751	0.059631834788969315
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.000915751	0.059631834788969315
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000915751	0.059631834788969315
MEGALENCEPHALY WITH DYSMYELINATION	0.000915751	0.059631834788969315
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000915751	0.059631834788969315
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000915751	0.059631834788969315
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.000915751	0.059631834788969315
HYPERPROLINEMIA, TYPE II	0.000915751	0.059631834788969315
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.000915751	0.059631834788969315
FRAGILE X MENTAL RETARDATION SYNDROME	0.000915751	0.059631834788969315
CYCLIC VOMITING SYNDROME	0.000915751	0.059631834788969315
RETINAL DEGENERATION AND EPILEPSY	0.000915751	0.059631834788969315
AUSTRALIA ANTIGEN	0.000843882	0.054951872294308174
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.000843882	0.054951872294308174
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.000843882	0.054951872294308174
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.000843882	0.054951872294308174
HURLER SYNDROME	0.000843882	0.054951872294308174
CHOPS SYNDROME; CHOPS	0.000843882	0.054951872294308174
#614976 CARPENTER SYNDROME 2; CRPT2	0.000843882	0.054951872294308174
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.000843882	0.054951872294308174
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000843882	0.054951872294308174
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000843882	0.054951872294308174
RICHARDS-RUNDLE SYNDROME; RRNS	0.000843882	0.054951872294308174
#607694 LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/ORHYPOGONADOTROPIC HYPOGONADISM; HLD7;;LEUKOENCEPHALOPATHY, HYPOMYELINATING, WITH ATAXIA AND DELAYED DENTITION;;ATAXIA, DELAYED DENTITION, AND HYPOMYELINATION; ADDH;;LEUKODYSTROPHY, HYPOMYELINATING, WITH HYPODONTIA AND HYPOGONADOTROPICHYPOGONADISM;;4H SYNDROME	0.000843882	0.054951872294308174
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.000843882	0.054951872294308174
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000843882	0.054951872294308174
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.000843882	0.054951872294308174
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.000843882	0.054951872294308174
JOUBERT SYNDROME 31; JBTS31	0.000843882	0.054951872294308174
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000843882	0.054951872294308174
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000843882	0.054951872294308174
JOUBERT SYNDROME 10	0.000843882	0.054951872294308174
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000843882	0.054951872294308174
#609528 CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMASYNDROME;;CEDNIK SYNDROME	0.000843882	0.054951872294308174
POPOV-CHANG SYNDROME; POPCHAS	0.000843882	0.054951872294308174
LAMB-SHAFFER SYNDROME	0.000843882	0.054951872294308174
NAVAJO NEUROHEPATOPATHY	0.000843882	0.054951872294308174
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.000843882	0.054951872294308174
ELSAHY-WATERS SYNDROME; ESWS	0.000843882	0.054951872294308174
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.000843882	0.054951872294308174
HOLOPROSENCEPHALY 11	0.000843882	0.054951872294308174
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.000843882	0.054951872294308174
MECKEL SYNDROME 13; MKS13	0.000843882	0.054951872294308174
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.000843882	0.054951872294308174
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000843882	0.054951872294308174
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000843882	0.054951872294308174
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.000843882	0.054951872294308174
#609425 CHROMOSOME 3q29 DELETION SYNDROME;;MICRODELETION 3q29 SYNDROME	0.000843882	0.054951872294308174
SENIOR-LOKEN SYNDROME 9	0.000843882	0.054951872294308174
CEREBELLOFACIODENTAL SYNDROME	0.000843882	0.054951872294308174
MEVALONIC ACIDURIA; MEVA	0.000843882	0.054951872294308174
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.000843882	0.054951872294308174
BARDET-BIEDL SYNDROME 13; BBS13	0.000843882	0.054951872294308174
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.000843882	0.054951872294308174
NOONAN SYNDROME 11; NS11	0.000843882	0.054951872294308174
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000843882	0.054951872294308174
#227810 FANCONI-BICKEL SYNDROME; FBS;;HEPATORENAL GLYCOGENOSIS WITH RENAL FANCONI SYNDROME;;HEPATIC GLYCOGENOSIS WITH FANCONI NEPHROPATHY;;HEPATIC GLYCOGENOSIS WITH AMINO ACIDURIA AND GLUCOSURIA;;FANCONI SYNDROME WITH INTESTINAL MALABSORPTION AND GALACTOSE INTOLERANCE;;PSEUDO-PHLORIZIN DIABETES;;GLYCOGENOSIS, FANCONI TYPE;;GLYCOGEN STORAGE DISEASE XI	0.000843882	0.054951872294308174
#275900 SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20;;TROYER SYNDROME;;SPASTIC PARAPARESIS, CHILDHOOD-ONSET, WITH DISTAL MUSCLE WASTING;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, TROYER TYPE	0.000843882	0.054951872294308174
SEPTOOPTIC DYSPLASIA	0.000843882	0.054951872294308174
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.000843882	0.054951872294308174
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000843882	0.054951872294308174
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000843882	0.054951872294308174
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000843882	0.054951872294308174
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000843882	0.054951872294308174
BARDET-BIEDL SYNDROME 17; BBS17	0.000843882	0.054951872294308174
#615066 OSTEOGENESIS IMPERFECTA, TYPE XIV; OI14 ;;OI, TYPE XIV	0.000843882	0.054951872294308174
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.000843882	0.054951872294308174
Bardet-Biedl syndrome 2	0.000843882	0.054951872294308174
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.000843882	0.054951872294308174
ALAZAMI SYNDROME; ALAZS	0.000843882	0.054951872294308174
CDAGS SYNDROME	0.000843882	0.054951872294308174
#613076 MYOPATHY, MITOCHONDRIAL PROGRESSIVE, WITH CONGENITAL CATARACT, HEARINGLOSS, AND DEVELOPMENTAL DELAY;;MYOPATHY WITH CATARACT AND COMBINED RESPIRATORY CHAIN DEFICIENCY;;MITOCHONDRIAL COMPLEX DEFICIENCY, COMBINED	0.000843882	0.054951872294308174
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000843882	0.054951872294308174
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000843882	0.054951872294308174
OCULOSKELETODENTAL SYNDROME; OCSKD	0.000843882	0.054951872294308174
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000843882	0.054951872294308174
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.000843882	0.054951872294308174
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.000843882	0.054951872294308174
JOUBERT SYNDROME 17; JBTS17	0.000843882	0.054951872294308174
AICARDI-GOUTIERES SYNDROME 5	0.000843882	0.054951872294308174
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.000843882	0.054951872294308174
ROSSELLI-GULIENETTI SYNDROME	0.000843882	0.054951872294308174
EVEN-PLUS SYNDROME	0.000843882	0.054951872294308174
Leukotriene C4 synthase deficiency	0.000843882	0.054951872294308174
CHROMOSOME 17P13.1 DELETION SYNDROME	0.000843882	0.054951872294308174
#615220 OSTEOGENESIS IMPERFECTA, TYPE XV; OI15;;OI, TYPE XV	0.000843882	0.054951872294308174
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.000843882	0.054951872294308174
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.000843882	0.054951872294308174
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000843882	0.054951872294308174
NIEMANN-PICK DISEASE, TYPE A	0.000843882	0.054951872294308174
#610185 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME2; CAMRQ2;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 2	0.000843882	0.054951872294308174
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.000843882	0.054951872294308174
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000843882	0.054951872294308174
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.000843882	0.054951872294308174
OROTIC ACIDURIA	0.000843882	0.054951872294308174
CREE MENTAL RETARDATION SYNDROME	0.000843882	0.054951872294308174
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.000843882	0.054951872294308174
MACROCEPHALY/AUTISM SYNDROME	0.000843882	0.054951872294308174
OROFACIODIGITAL SYNDROME IX; OFD9	0.000843882	0.054951872294308174
BARDET-BIEDL SYNDROME 14; BBS14	0.000843882	0.054951872294308174
#613603 CHROMOSOME 4q32.1-q32.2 TRIPLICATION SYNDROME	0.000843882	0.054951872294308174
CHROMOSOME 15q25 DELETION SYNDROME	0.000843882	0.054951872294308174
CURRY-JONES SYNDROME	0.000843882	0.054951872294308174
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.000843882	0.054951872294308174
TONNE-KALSCHEUER SYNDROME; TOKAS	0.000843882	0.054951872294308174
#615033 SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE; SPG54	0.000843882	0.054951872294308174
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000843882	0.054951872294308174
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000843882	0.054951872294308174
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000843882	0.054951872294308174
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000843882	0.054951872294308174
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000843882	0.054951872294308174
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000843882	0.054951872294308174
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000843882	0.054951872294308174
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000843882	0.054951872294308174
HYDROCEPHALUS, NORMAL-PRESSURE	0.000843882	0.054951872294308174
#608443 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 3; MRT3	0.000843882	0.054951872294308174
GENITOPATELLAR SYNDROME; GTPTS	0.000843882	0.054951872294308174
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.000843882	0.054951872294308174
JOUBERT SYNDROME 14	0.000843882	0.054951872294308174
#268310 ROBINOW SYNDROME, AUTOSOMAL RECESSIVE; RRS;;COSTOVERTEBRAL SEGMENTATION DEFECT WITH MESOMELIA, FORMERLY;;COVESDEM SYNDROME, FORMERLYROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH APLASIA/HYPOPLASIA OFPHALANGES AND METACARPALS/METATARSALS, INCLUDED;;ROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH BRACHY-SYN-POLYDACTYLY,INCLUDED	0.000843882	0.054951872294308174
THANATOPHORIC DYSPLASIA, TYPE I	0.000843882	0.054951872294308174
FRIAS SYNDROME	0.000843882	0.054951872294308174
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000843882	0.054951872294308174
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000843882	0.054951872294308174
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.000843882	0.054951872294308174
IMMUNODEFICIENCY 23; IMD23	0.000843882	0.054951872294308174
AL-RAQAD SYNDROME; ARS	0.000843882	0.054951872294308174
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000843882	0.054951872294308174
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.000843882	0.054951872294308174
COFFIN-SIRIS SYNDROME 6; CSS6	0.000843882	0.054951872294308174
ADAMS-OLIVER SYNDROME 3; AOS3	0.000843882	0.054951872294308174
#614701 CORNELIA DE LANGE SYNDROME 4; CDLS4	0.000843882	0.054951872294308174
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000843882	0.054951872294308174
Jawad syndrome	0.000843882	0.054951872294308174
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000843882	0.054951872294308174
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.000843882	0.054951872294308174
GOLDBERG-SHPRINTZEN SYNDROME	0.000843882	0.054951872294308174
Temtamy preaxial brachydactyly syndrome	0.000843882	0.054951872294308174
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.000843882	0.054951872294308174
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.000843882	0.054951872294308174
AICARDI-GOUTIERES SYNDROME 6	0.000843882	0.054951872294308174
NOONAN SYNDROME 9; NS9	0.000843882	0.054951872294308174
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.000843882	0.054951872294308174
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000843882	0.054951872294308174
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.000843882	0.054951872294308174
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000843882	0.054951872294308174
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.000843882	0.054951872294308174
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000843882	0.054951872294308174
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000843882	0.054951872294308174
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000843882	0.054951872294308174
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.000843882	0.054951872294308174
Cerebral creatine deficiency syndrome 3	0.000843882	0.054951872294308174
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 1; CEMCOX1	0.000843882	0.054951872294308174
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.000843882	0.054951872294308174
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000843882	0.054951872294308174
OROFACIODIGITAL SYNDROME XIV; OFD14	0.000843882	0.054951872294308174
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000843882	0.054951872294308174
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.000843882	0.054951872294308174
MEIER-GORLIN SYNDROME 7	0.000843882	0.054951872294308174
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000843882	0.054951872294308174
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000843882	0.054951872294308174
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000843882	0.054951872294308174
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.000843882	0.054951872294308174
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000843882	0.054951872294308174
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.000843882	0.054951872294308174
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000843882	0.054951872294308174
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000843882	0.054951872294308174
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000843882	0.054951872294308174
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.000843882	0.054951872294308174
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.000843882	0.054951872294308174
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000843882	0.054951872294308174
PEROXISOME BIOGENESIS DISORDER 3B	0.000843882	0.054951872294308174
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000843882	0.054951872294308174
#614402 MICROPHTHALMIA, SYNDROMIC 11; MCOPS11	0.000843882	0.054951872294308174
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.000843882	0.054951872294308174
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000843882	0.054951872294308174
JOUBERT SYNDROME 15	0.000843882	0.054951872294308174
#614970 JOUBERT SYNDROME 20; JBTS20	0.000843882	0.054951872294308174
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000843882	0.054951872294308174
GALACTOSE EPIMERASE DEFICIENCY	0.000843882	0.054951872294308174
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.000843882	0.054951872294308174
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000843882	0.054951872294308174
#607454 SPINOCEREBELLAR ATAXIA 21; SCA21	0.000843882	0.054951872294308174
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.000843882	0.054951872294308174
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.000843882	0.054951872294308174
#300895 OHDO SYNDROME, X-LINKED; OHDOX;;BLEPHAROPHIMOSIS-MENTAL RETARDATION SYNDROME, MAAT-KIEVIT-BRUNNERTYPE	0.000843882	0.054951872294308174
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000843882	0.054951872294308174
#610915 OSTEOGENESIS IMPERFECTA, TYPE VIII; OI8;;OI, TYPE VIII	0.000843882	0.054951872294308174
#604804 MICROCEPHALY 3, PRIMARY, AUTOSOMAL RECESSIVE; MCPH3	0.000843882	0.054951872294308174
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.000843882	0.054951872294308174
RAINE SYNDROME	0.000843882	0.054951872294308174
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000843882	0.054951872294308174
NETHERTON SYNDROME; NETH	0.000843882	0.054951872294308174
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000843882	0.054951872294308174
#614582 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9; COXPD9	0.000843882	0.054951872294308174
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.000843882	0.054951872294308174
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.000843882	0.054951872294308174
HOLOPROSENCEPHALY 5; HPE5	0.000843882	0.054951872294308174
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000843882	0.054951872294308174
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.000843882	0.054951872294308174
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000843882	0.054951872294308174
#615314 CRANIOSYNOSTOSIS 3; CRS3	0.000843882	0.054951872294308174
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000843882	0.054951872294308174
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000843882	0.054951872294308174
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.000843882	0.054951872294308174
JOUBERT SYNDROME 8	0.000843882	0.054951872294308174
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.000843882	0.054951872294308174
#180700 ROBINOW SYNDROME, AUTOSOMAL DOMINANT; DRS;;ROBINOW DWARFISM;;FETAL FACE SYNDROME;;ACRAL DYSOSTOSIS WITH FACIAL AND GENITAL ABNORMALITIES	0.000843882	0.054951872294308174
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000843882	0.054951872294308174
FORSYTHE-WAKELING SYNDROME; FWS	0.000843882	0.054951872294308174
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.000843882	0.054951872294308174
OGDEN SYNDROME; OGDNS	0.000843882	0.054951872294308174
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000843882	0.054951872294308174
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.000843882	0.054951872294308174
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.000843882	0.054951872294308174
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.000843882	0.054951872294308174
CHROMOSOME 17q23.1-q23.2 DELETION SYNDROME	0.000843882	0.054951872294308174
TOWNES-BROCKS SYNDROME 1; TBS1	0.000843882	0.054951872294308174
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.000843882	0.054951872294308174
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000843882	0.054951872294308174
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000843882	0.054951872294308174
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000843882	0.054951872294308174
#267000 PERLMAN SYNDROME; PRLMNS;;RENAL HAMARTOMAS, NEPHROBLASTOMATOSIS, AND FETAL GIGANTISM;;NEPHROBLASTOMATOSIS, FETAL ASCITES, MACROSOMIA, AND WILMS TUMOR	0.000843882	0.054951872294308174
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.000843882	0.054951872294308174
MARINESCO-SJOGREN SYNDROME; MSS	0.000843882	0.054951872294308174
AU-KLINE SYNDROME; AUKS	0.000843882	0.054951872294308174
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000843882	0.054951872294308174
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000843882	0.054951872294308174
#610168 LOEYS-DIETZ SYNDROME 2; LDS2;;AORTIC ANEURYSM, FAMILIAL THORACIC 3; AAT3;;MARFAN SYNDROME, TYPE II, FORMERLY	0.000843882	0.054951872294308174
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000843882	0.054951872294308174
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000843882	0.054951872294308174
#615432 SPECIFIC LANGUAGE IMPAIRMENT 5; SLI5	0.000843882	0.054951872294308174
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000843882	0.054951872294308174
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.000843882	0.054951872294308174
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.000843882	0.054951872294308174
#614213 NEUROPATHY, HEREDITARY SENSORY, TYPE IIC; HSN2C	0.000843882	0.054951872294308174
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.000843882	0.054951872294308174
#615280 CARDIOFACIOCUTANEOUS SYNDROME 4; CFC4	0.000843882	0.054951872294308174
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.000843882	0.054951872294308174
NOONAN SYNDROME 6; NS6	0.000843882	0.054951872294308174
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000843882	0.054951872294308174
DIAMOND-BLACKFAN ANEMIA 5	0.000843882	0.054951872294308174
#170100 PROLIDASE DEFICIENCY	0.000843882	0.054951872294308174
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.000843882	0.054951872294308174
HOLOPROSENCEPHALY 3; HPE3	0.000843882	0.054951872294308174
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.000843882	0.054951872294308174
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000843882	0.054951872294308174
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.000843882	0.054951872294308174
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000843882	0.054951872294308174
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.000843882	0.054951872294308174
#611936 CHROMOSOME 3q29 DUPLICATION SYNDROME;;MICRODUPLICATION 3q29 SYNDROME	0.000843882	0.054951872294308174
#615401 IMMUNODEFICIENCY 8; IMD8	0.000843882	0.054951872294308174
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.000843882	0.054951872294308174
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000843882	0.054951872294308174
CULLER-JONES SYNDROME; CJS	0.000843882	0.054951872294308174
CHROMOSOME 15Q14 DELETION SYNDROME	0.000843882	0.054951872294308174
CHROMOSOME 9P DELETION SYNDROME	0.000843882	0.054951872294308174
#300123 MENTAL RETARDATION, X-LINKED, WITH PANHYPOPITUITARISMMENTAL RETARDATION, X-LINKED, WITH ISOLATED GROWTH HORMONE DEFICIENCY,INCLUDED; MRGH, INCLUDED	0.000843882	0.054951872294308174
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.000843882	0.054951872294308174
#231550 ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS;;TRIPLE-A SYNDROME;;ALACRIMA-ACHALASIA-ADRENAL INSUFFICIENCY NEUROLOGIC DISORDER;;GLUCOCORTICOID DEFICIENCY AND ACHALASIA;;ALLGROVE SYNDROME;;ADDISONIAN-ACHALASIA SYNDROME;;HYPOADRENALISM WITH ACHALASIA;;ALACRIMA-ACHALASIA-ADDISONIANISM;;ACTH-RESISTANT ADRENAL INSUFFICIENCY, ACHALASIA AND ALACRIMAACHALASIA-ALACRIMA SYNDROME, INCLUDED	0.000843882	0.054951872294308174
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000843882	0.054951872294308174
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.000843882	0.054951872294308174
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.000843882	0.054951872294308174
THAUVIN-ROBINET-FAIVRE SYNDROME	0.000843882	0.054951872294308174
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.000843882	0.054951872294308174
NOONAN SYNDROME 3; NS3	0.000843882	0.054951872294308174
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000843882	0.054951872294308174
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.000843882	0.054951872294308174
CHROMOSOME 16Q22 DELETION SYNDROME	0.000843882	0.054951872294308174
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000843882	0.054951872294308174
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000843882	0.054951872294308174
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000843882	0.054951872294308174
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.000843882	0.054951872294308174
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.000843882	0.054951872294308174
#615278 CARDIOFACIOCUTANEOUS SYNDROME 2; CFC2	0.000843882	0.054951872294308174
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000843882	0.054951872294308174
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.000843882	0.054951872294308174
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000843882	0.054951872294308174
SECKEL SYNDROME 8; SCKL8	0.000843882	0.054951872294308174
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.000843882	0.054951872294308174
#613752 HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.000843882	0.054951872294308174
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000843882	0.054951872294308174
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000843882	0.054951872294308174
HADZISELIMOVIC SYNDROME	0.000843882	0.054951872294308174
#615541 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39; MRT39	0.000843882	0.054951872294308174
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000843882	0.054951872294308174
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.000843882	0.054951872294308174
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.000843882	0.054951872294308174
3MC SYNDROME 2	0.000843882	0.054951872294308174
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000843882	0.054951872294308174
CHAR SYNDROME	0.000843882	0.054951872294308174
#614728 SECKEL SYNDROME 6; SCKL6	0.000843882	0.054951872294308174
NEPHRONOPHTHISIS 11; NPHP11	0.000843882	0.054951872294308174
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.000843882	0.054951872294308174
JOUBERT SYNDROME 32; JBTS32	0.000843882	0.054951872294308174
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.000843882	0.054951872294308174
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.000843882	0.054951872294308174
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000843882	0.054951872294308174
FRONTOOCULAR SYNDROME	0.000843882	0.054951872294308174
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000843882	0.054951872294308174
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.000843882	0.054951872294308174
COHEN-GIBSON SYNDROME; COGIS	0.000843882	0.054951872294308174
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.000843882	0.054951872294308174
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000843882	0.054951872294308174
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000843882	0.054951872294308174
LIG4 SYNDROME	0.000843882	0.054951872294308174
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000843882	0.054951872294308174
#613641 CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE B; CMTRIB;;CHARCOT-MARIE-TOOTH NEUROPATHY, RECESSIVE INTERMEDIATE B; RI-CMTB	0.000843882	0.054951872294308174
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000843882	0.054951872294308174
#612714 EXOCRINE PANCREATIC INSUFFICIENCY, DYSERYTHROPOIETIC ANEMIA, AND CALVARIALHYPEROSTOSIS	0.000843882	0.054951872294308174
CHROMOSOME 4q21 DELETION SYNDROME	0.000843882	0.054951872294308174
JOUBERT SYNDROME 26	0.000843882	0.054951872294308174
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.000843882	0.054951872294308174
WAARDENBURG-SHAH SYNDROME	0.000843882	0.054951872294308174
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000843882	0.054951872294308174
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000843882	0.054951872294308174
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000843882	0.054951872294308174
CHROMOSOME 18P DELETION SYNDROME	0.000843882	0.054951872294308174
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.000843882	0.054951872294308174
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.000843882	0.054951872294308174
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000843882	0.054951872294308174
JOUBERT SYNDROME 25	0.000843882	0.054951872294308174
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.000843882	0.054951872294308174
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.000843882	0.054951872294308174
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.000843882	0.054951872294308174
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000843882	0.054951872294308174
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.000843882	0.054951872294308174
LARSEN-LIKE SYNDROME	0.000843882	0.054951872294308174
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.000843882	0.054951872294308174
CRANIOFRONTONASAL SYNDROME; CFNS	0.000843882	0.054951872294308174
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.000843882	0.054951872294308174
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000843882	0.054951872294308174
BARDET-BIEDL SYNDROME 8; BBS8	0.000843882	0.054951872294308174
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.000843882	0.054951872294308174
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000843882	0.054951872294308174
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000843882	0.054951872294308174
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.000843882	0.054951872294308174
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000843882	0.054951872294308174
METHYLMALONIC ACIDURIA, CBLB TYPE	0.000843882	0.054951872294308174
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000843882	0.054951872294308174
STEEL SYNDROME; STLS	0.000843882	0.054951872294308174
JOUBERT SYNDROME 27	0.000843882	0.054951872294308174
LYMPHEDEMA, HEREDITARY, III	0.000843882	0.054951872294308174
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000843882	0.054951872294308174
NOONAN SYNDROME 2; NS2	0.000843882	0.054951872294308174
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.000843882	0.054951872294308174
MICROPHTHALMIA, SYNDROMIC 3	0.000843882	0.054951872294308174
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.000843882	0.054951872294308174
BARDET-BIEDL SYNDROME 3; BBS3	0.000843882	0.054951872294308174
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.000843882	0.054951872294308174
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.000843882	0.054951872294308174
#300555 DENT DISEASE 2	0.000843882	0.054951872294308174
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.000843882	0.054951872294308174
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.000843882	0.054951872294308174
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000843882	0.054951872294308174
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000843882	0.054951872294308174
BARDET-BIEDL SYNDROME 16; BBS16	0.000843882	0.054951872294308174
OROFACIODIGITAL SYNDROME VI	0.000843882	0.054951872294308174
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.000843882	0.054951872294308174
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.000843882	0.054951872294308174
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig; CDG1G	0.000843882	0.054951872294308174
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000843882	0.054951872294308174
PEROXISOME BIOGENESIS DISORDER 10B	0.000843882	0.054951872294308174
CRANIOTELENCEPHALIC DYSPLASIA	0.000843882	0.054951872294308174
JOUBERT SYNDROME 28	0.000843882	0.054951872294308174
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000843882	0.054951872294308174
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000843882	0.054951872294308174
MENTAL RETARDATION, X-LINKED 99	0.000843882	0.054951872294308174
CRANIOSYNOSTOSIS 6; CRS6	0.000843882	0.054951872294308174
NOONAN SYNDROME 5; NS5	0.000843882	0.054951872294308174
300270 ADRENOMYODYSTROPHY	0.000843882	0.054951872294308174
#615583 VERHEIJ SYNDROME; VRJS;;CHROMOSOME 8q24.3 DELETION SYNDROME	0.000843882	0.054951872294308174
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.000843882	0.054951872294308174
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.000843882	0.054951872294308174
PELLAGRA-LIKE SYNDROME	0.000843882	0.054951872294308174
CHROMOSOME 10q22.3-q23.2 DELETION SYNDROME	0.000843882	0.054951872294308174
SWEENEY-COX SYNDROME; SWCOS	0.000843882	0.054951872294308174
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000843882	0.054951872294308174
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000843882	0.054951872294308174
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.000843882	0.054951872294308174
